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Deep sea hydrothermal vents located along ocean ridges harbor microorganisms with 
unique adaptations. These extremophiles have adapted to high temperature and 
extreme conditions. Carbohydrate acting enzymes with thermostable properties are an 
increasing interest for industrial usage, as their extreme nature enable processes to 
be performed more efficiently, lower contamination and overall cost. In this study we 
work with a metagenome that was retrieved from a hydrothermal vent located at Bruse 
vent site, and then annotated for carbohydrate active enzyme function. From the 
metagenome 34 sequences were annotated with Carbohydrate Binding Module 9 
(CBM9) but lacking enzyme classes. These were further analyzed to determine if they 
contained signal peptide, transmembrane helices, and two putative xylanases were 
chosen for further analysis. Two putative xylanases and five annotated α-amylase were 
placed in pET21a vector, transformed and expressed in E. coli with heterologous 
protein expression. The target proteins were purified with histidine affinity tag, and 
enzyme activity was tested through plate assay with xylan and starch substrate. 
Neopullulanase from a published isolate Geobacillus sp. 12AMOR1 was also purified 
with histidine affinity tag, and the oligomeric state was estimated through size exclusion 
chromatography. The putative xylanases were expressed as inclusion bodies, purified 
under denatured conditions and dialyzed. No activity was observed when tested on 
plates containing xylan, incubated at 65°C for 4 hours. Two of the annotated α-
amylases were expressed as soluble proteins, purified under denatured conditions and 
dialyzed. No activity was observed when tested on plates containing starch, incubated 
at 65°C for 4 hours. Based on SDS-PAGE and gel filtration the neopullanase’s 
oligomeric state was estimated to be a dimer. To achieve active proteins for the 
putative xylanases we suggest the use of fusion partners to obtain soluble protein, for 
the α-amylases purification with new histidine tag or ion exchange chromatography to 
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1.Introduction  
1.1 Bioprospecting of deeps-sea hydrothermal vents. 
Deep-sea hydrothermal vents are volcanic vents known as black smoker located along 
the ridges where tectonic activity occur (Figure 1). These hydrothermal vents are 
known for their tall chimneys with a plum of black smoke exiting these vents (Dick, 
2019). Fractures around these vents allow seawater to seep down in the sediment, 
where deep enough its super-heated and pushed out trough channels. Down in the 
sediment the water is loaded with minerals and dissolved gasses that is carried out 
with the water flow. This creates a unique geochemical profile when the mineral rich 
water is mixed with cold ocean water. Water exiting these chimneys can reach a 
temperature of 400°C due to the high pressure while temperature around the chimneys 
are cold (Webber et al., 2015). Around the chimneys the temperature and pH gradient 
are step. The sediment surrounding these vents with are also heated from below by 
the warm water exiting the vents and seeping outside. 
 
 
Microorganisms that live in environments with extremes of high or low, temperature, 
pH, salinity or pressure are known as extremophiles. These microorganisms have 
adaptation and mechanisms that ensure survival in these conditions. High temperature 
denatures mesophilic enzymes as the heat breaks the bonds in the proteins. 
Thermophiles (45°C<) and hyperthermophiles (80°C<) have adaptions that stabilizes 
the proteins to avoid denaturing and remaining active. Acidophiles (pH < 5.5) and 
alkaliphile (pH > 8) maintain a neutral internal pH inside the cell compared to the 
environment their live inn (Madigan et al., 2019). Extremophiles can have multiple 
7 
 
adaptations, depending on the environment they are located in, with conditions in deep 
sea hydrothermal vents with high pressure, low pH and high temperatures are some 
extreme conditions.  
 
Figure 1 Map displaying the distribution of over 700 hydrothermal vents. Confirmed active vents (Red circles), 
active inferred (yellow circles) and extinct vents (Blue circles). Retrieved from: (Beaulieu et al., 2020) 
Properties that these microorganisms harbor makes them attractive targets in 
biotechnology. Biotechnology is a technology based on biology and is applied various 
industrial processes or be utilized for scientific purposes (Madigan et al., 2019). With 
genetic engineering microorganisms can be manipulated to produce metabolites or 
other processes that can be harvested (Madigan et al., 2019).   
Especially, enzymes of these extremophilic microorganisms have received much 
interest from Industry as their ability withstand extreme conditions and their cellular 
components adaptations. Applications and usage from pharmaceuticals, agriculture, 
pulp and paper industry to food and beverage (Demain & Adrio, 2007). Food beverage 
market has an increasing interest as processes that can be done at a higher 
temperature increases the efficiency, reduces amount of enzymes needed and 
therefore the overall cost. Enzymes with a higher optimum temperature lower the 
possibly of contaminant in the process (Sarmiento et al., 2015). 
Metagenomics is the sequencing and analysis of the total genetic material from an 
environmental sample (Kodzius & Gojobori, 2015). This has been a well-recognized 
method to obtain genetic samples from extremophiles, as this eliminate the need to 
isolate and cultivate the microbes, as replicating their conditions and locating the 
microbes can be difficult (DeCastro et al., 2016). Metagenomics can be a starting point 
when bioprospecting for novel enzymes, as sample sites chosen reflects the properties 
wanted from the enzyme. Bioprospecting is the process of looking biological entities 
that can be used and improved for commercial use. With this approach for finding novel 
thermostable enzymes, the conditions from environment should reflect these 
properties.  
With a metagenomic approach, the first step is taking the environmental sample from 
the source of interest. Sample is prepared and purified from contaminants,  
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DNA extraction ensures that all available DNA content in the sample is available and 
is achieved by cell lysis. Important to consider is factors that can hinder cell lysis and 
increase stability. 
Cell lysis can be broken down in 4 categories, mechanical including bead beating and 
sonication, thermal with freezing and boiling, chemical with SDS and enzymatic with 
lysozyme. Each category has multiple way of rupturing cells, these mention are just a 
few examples (Felczykowska et al., 2015). The goal is to ensure that all cells burst and 
release their genetic material, a combination of different types of cell lysis can be 
combined be utilized.  
Sequencing allows for the biological genetic information to be translated to digital 
information that can be interpreted and analyzed further, and advancements here is a 
major driving force that has allowed the advancement of metagenomics to happened. 
Illumina sequencing and next generation shotgun sequencing are methods that splits 
the metagenome into fragments that are sequenced simultaneously (Chiu & Miller, 
2019). Overlapping fragments are assembled into continuous sequences (contigs). 
Predicted metagenome-assembled genomes (MAGs) are sorted in bins, and open 
reading frames (ORF) can be annotated (Kieser et al., 2020). Taxonomic annotation 
with homology search in databases used to map out the organisms in the sample and 
functional annotation to map out the activity present in the metagenome (Tamames et 
al., 2019). 
Heterologous protein expression is a powerful tool in biochemistry, that gives the ability 
to utilize the machinery of the host cell to produce proteins of interest. Heterologous 
protein expression is the introduction of complementary DNA or RNA encoding for a 
protein from one species and expressed in another host species (Gagnon, 2010). 
Commonly used in protein studies such as bioprospecting to obtain functional proteins 
of interest. Different organisms are used in heterologous protein expression and have 
different strengths and weaknesses, unicellular algae, yeast and bacteria are some 
common examples. E. coli is a widely used host organisms because of fast growth, 
low maintenance, cheap and huge variety of competent strains specialized for different 
expression (Rosano & Ceccarelli, 2014). Transferring gen of interest to E. coli is 
achieved with a vector contain the gene with other regulatory factors, selective factors 
and markers. pET-21a vector is a widely used expression vector used in E. coli that 
contains ampicillin resistance for selection1, T7 promotor that regulates target gene 
expression and a His-tag that tags the expressed protein for protein purification. 
Vectors can be inserted in the host cell by transformation, the procaryotic mechanism 
for absorption of environmental DNA. Heat shock or electric shock are methods to 
increase the transformation rate. 
The goal for heterologous protein expression is to obtain a large amount of functional 
correct folded protein from the gene of interest. Several factors can influence the 
success rate of protein expression. Extracellular proteins from prokaryotic origin 
contains a signal peptide, which is an N terminal peptide that helps export the protein. 





ATP hydrolysis to export the unfolded protein out of the cell where the signal peptide 
is then removed. The second Sec/SPII lipoprotein signal peptide is transported by the 
Sec translocon and cleaved by Signal Peptidase II. The third Tat/SPI signal peptide is 
driven by the proton motive force and exported partly folded proteins that contains 
cofactors (Stahl et al., 2015). To avoid protein loss during heterologous protein 
expression these signal peptides are removed before synthesized in a vector. 
Membrane associated proteins contains a transmembrane helix, which is also 
important to check for and consider before doing protein expression, as this could 
affect the result (Wong et al., 2012). 
Codon optimization is an important tool to obtain recombinant proteins by eliminating 
codon bias. Expression of foreign DNA in a host cell might encounter codon bias if 
codon optimization is not performed before protein expression. The frequency of 
codons used in a species is related to the corresponding tRNA and amino acids 
available during translation and protein expression (Fu et al., 2020). Codon usage vary 
to different degrees between organisms, and some may utilize different codons for the 
same amino acids, these rare codon are the limiting factor and can halter translation 
or protein expression. Codon optimization uses synonymous codons to avoid rare 
codons from the foreign DNA in the host organism and increasing protein expression 
(Mauro & Chappell, 2014). 
 
1.2 Carbohydrate-acting enzymes in biotechnology 
Carbohydrate-acting enzymes (CAZymes) have important metabolic roles in all forms 
of life and widely used in biotechnology such as biorefinery, food, feed, paper, pulp 
and detergent industry (Chettri et al., 2020; Kirk et al., 2002). CAZymes are divided in 
classes based on the activity, glycoside hydrolases (GH), glycosyltransferases (GT), 
polysaccharide lyses (PL), carbohydrate esterases (CE) and auxiliary activities (AA). 
Associated modules are carbohydrate binding modules (CBM) that binds to the 
substrate (Corrêa et al., 2020). To this day 88 families of CBM are described and in 
the CAZy database (Lombard et al., 2014). The two most abundant renewable biomass 
recourses on earth is cellulose and starch (Mischnick & Momcilovic, 2010). Finding 
novel enzymes with physicochemical properties to fully utilize the potential of these 
resources are high interest in biotechnology. Amylolytic are some popular enzymes 
used in the industry for the conversion of starch to monomer sugars with synorogenic 
mix of enzymes. Amylases are enzymes capable of this hydrolytic activity and are 
classified according to the specificity they operate (Fia et al., 2005). Xylan is main 
carbohydrate in hemicellulose found in plant cell walls (Subramaniyan & Prema, 2002). 
Xylanase is the enzyme that hydrolysis xylan, two known enzymes have this activity.   
Endo-1,4- β- xylanase with endohydrolysis of (1-4) β-D-xylosidic linkages in xylan and 
α-D-xylosidase with hydrolysis of terminal, non-reducing α-D-xylose residues with 




1.3 (Meta)genomics-based enzyme discovery at AMOR 
The genes focused on in this project are encoded by microorganisms from the Arctic 
Mid-Ocean Ridge (AMOR) vent fields. Three vent sites have been discovered 50 km 
north of the Jan Mayen fracture zone, the Troll Wall, Soria Moria vent site and Bruse 
vent site (Figure 2. 5) in The Jan Mayen hydrothermal Vent field (JMVF).The Bruse 
vent site is located 71°18’N, 05°42’W with a depth of 570 meters below the surface 
(Stokke et al., 2020). 
 
Figure 2 Map of the Artic mid-ocean ridge vent field. Source: Rolf B. Pedersen (Centres for Geobiology and Deep 
Sea Research, University of Bergen), Terje Bjerkgård (Geological Survey of Norway), 2016, Chapter 5: Sea-Floor 
Massive Sulphides in the Arctic Waters 
 
 
In 2014 titanium incubators were placed in the hot sediment surrounding the 
hydrothermal vents at the Bruse vent site (Stokke et al., 2020) with an ROV (Remotely 
Operated Vehicle). The incubators had 3 chambers each with a volume of 16 ml 
arranged on top each other (Figure 3.B). They were filled with 16ml sediment from the 
vent site and supplemented with 1g substrate. The incubators of interest for this project 
were filled with 1g of unbleached Norwegian spruce (Picea abies) that had been 
subjected to sulfite pulping pre-treatment from Borregaard AS (Sarpsborg, Norway) 
termed the BALI process (Rødsrud et al., 2012). The substrate in this incubator had a 
content of 85% glucan, acid insoluble lignin 8% and hemicelluloses 3% (mannan and 
xylan) (Fredriksen et al., 2019), and named CGB6. The second incubator used in this 
project, CGB9, was filled with wheat grains (unpublished results). Both incubators were 
deployed in the hydrothermal sediment at Bruse with a temperature gradient ranging 
from 20°C at the sediment surface to 74°C deeper in the sediment, allowing the three 
chambers of each incubator to be subjected to different temperatures. The incubators 





Figure 3 Overview of the in situ incubation performed at Bruse vents site. A) Bathymetry map showing depth of 
Bruse vent site. B) Schematic of CGB6 incubator with Sulfite-pulped spruce with depth location in the sediment 
centimeters below sea surface (cmbsf). C) Incubators placement in the hot hydrothermal sediment. D) Remotely 
operated vehicle used to deploy incubators in the sediment. Source (Stokke el al,. 2020)     
 
Metagenomic sequencing of which in situ incubators and subsequent expression and 
characterization of enzyme have provided knowledge of 4 unique carbohydrate 
degrading enzymes (Stokke et al., 2020). Thermostable alginate lyase AMOR_PL7A 
(Vuoristo et al., 2019), thermostable alginate lyase AMOR_PL17A (Arntzen et al., 
2021), hyperthermophilic novel GH9 cellulase (Stepnov et al., 2019), thermostable 




1.4 α-amylases GH13 and GH57  
Amylase is an class of carbohydrate-degrading enzymes that hydrolyze starch 
polymers to glucose monomers, α-amylase is the enzyme that cleaves the internal α-
1,4 polymer binding in starch (Dalmaso et al., 2015). α-amylases belonging to GH13 
is the most characterized of the amylases (Janeček et al., 2014), however, amylases 
belonging to GH57 often have a thermophilic origin (Jeon et al., 2014). Identifying novel 
α-amylases is still a focus of interest for new and improved applications in 
biotechnology. In 2016, Wissuwa et al. published the isolation and genome sequence 
of a thermophilic starch-degrading Geobacillus strain, isolated from hot sediments at 
the Jan Mayen hydrothermal vent site (Wissuwa et al., 2016). In addition, an enzyme 
from the GH13 family and annotated as a neopullulanase, was expressed and purified 
(Internal Locus tag; Geob_1869, GenBank Locus tag GARCT_00679; AKM17981). 
The purified enzyme showed starch-degrading capacity and high thermal stability with 
a melting temperature of 76.4 °C. To further assess the molecular weight and 
oligomeric state of the GH13 from Geobacillus sp. 12AMOR1, the target gene cloned 
in the pOPINE_F expression vector was used for expression and purification in E. coli 
BL21. Furthermore, the purified GH13 from Geobacillus was used as a control in plate 
assays together with α-amylase from Bacillus licheniformis (Sigma-Aldrich). 
From an in situ incubator (deployed and collected as for CGB6 described above) 
supplemented with starch as substrate (CGB9), sequences annotated as GH57 using 
the dbCAN annotation tool (http://bcb.unl.edu/dbCAN2/); run_dbCAN.py(Zhang et al., 
2018), was selected. True amylases of the GH57 family from the dbCAN annotation 
was identified based on alignments with GH57 from Janecek and Blesak 2011 
(Janeček & Blesák, 2011). 
 
1.5 Aim: 
This project aims to study biochemical properties of a selection of carbohydrate 
degrading enzymes originating from vent fields on the Arctic Mid-Ocean Ridge. The 
following sub-goals were set: 
1) Bioinformatic analyses of 34 putative carbohydrate degrading enzymes with an 
identified carbohydrate binding module 9 (CBM9)  
2) Based on this analysis, select 2 genes for cloning and expression trials 
3) Purify and verify activity using a simple agar plate enzyme assay in comparison 
to a published thermostable GH10 xylanase from the Arctic Mid-Ocean Vent 
Fields - AMOR_GH10A (Fredriksen et al., 2019).  
4) Perform expression trials on predicted proteins containing GH57 and do an agar 
plate enzyme assay to confirm the activity that reflect the protein domain.  
5) Purify and estimate the oligomeric state of a neopullulanase encoded by 




2.1 Competent cells  
Competent strain of Escherichia coli (E. coli) was used. Two types of BL21 (DE3) 
competent cells (Aligent Technologies, Santa Clara, USA) were used. E. coli BL21-
Gold (DE3) competent cells, genotype E. coli B F- ompT hsdS(rB- mb-) dcm+ Tetr gal 
l(DE3) endA The. Encodes T7 RNA polymerase under the control of the lacUV5 
promotor. The second, E. coli BL21-Gold (DE3) pLysS competent cells, genotype E. 
coli B F– ompT hsdS(rB– mB–) dcm+ Tetr gal l(DE3) endA Hte [pLysS Camr] 
 
2.2 Metagenomics-based selection of target enzymes 
Based on metagenomic analyses 34 CBM9-encoding protein sequences were provide 
by my supervisor Dr. Runar Stokke, and this selection was based on the following 
analyses performed by him. Metagenomic sequencing and assembly for the CGB6 
incubator was conducted as previously described (Fredriksen et al. 2019). The 
metagenomic sequencing and assembly of the wheat grain incubator, CGB9, was 
conducted similarly (unpublished, Stokke et al.). Open reading frame (ORFs) 
prediction of all potential genes was performed using Prodigal v.2.6.3 with the -p meta 
option enabled. All potential protein coding genes were analyzed for carbohydrate-
active enzymes (CAZymes) and carbohydrate binding modules (CBMs) using the 
standalone version of the dbCAN annotation tool (http://bcb.unl.edu/dbCAN2/); 
run_dbCAN.py (Zhang et al., 2018). As implemented in run_dbCAN.py, hmmscan and 
diamond blast was analyzed against the dbCAN HMMdb v8 (evalue cutoff 1E-5). 
Extracted hits were analyzed for signal peptides and transmembrane helices using 
standalone versions of SignalP5.0 (Almagro Armenteros et al., 2019) and TMHMM 2.0 
(Krogh et al., 2001; Sonnhammer et al., 1998), respectively. In order to cluster 
functional groups of glycosyl hydrolases (GHs) from the CGB6 incubator, the protein 
hits were analyzed with the EFI-ENZYME SIMILARITY TOOL which uses similarity 
networks (SSN) for visualization of relationships amongst protein sequences 
https://efi.igb.illinois.edu/efi-est/ (Gerlt et al., 2015). Hence, related proteins are 
grouped together in iso-functional clusters dependent on the threshold set in the 
analysis. The EFI tool was run twice. The overall SSN analysis was performed using a 
similarity cutoff of 35% and visualized in Cytoscape v3.7.2. For this work, the largest 
node containing the unique signature of CBM9, a xylanase binding module, was 
selected (Figure 4.A). The second run of the EFI tool was set to a higher cutoff (SSN 
alignments of 80% identity) to differentiate between possible iso-families within the 




Figure 4. Isolated cluster node comprised of CBM9-containing sequences; A) 35 % identity cutoff and B) 80 % 
identity cutoff. The final selected sequences synthesized for expression are marked in yellow. 
 
The GH13 from Geobacillus sp. 12AMOR1, target gene cloned in the pOPINE_F 
expression vector was used for expression and purification in E. coli BL21 (DE3). 
Furthermore, the purified GH13 from Geobacillus was used as a control in plate assays 
together with α-amylase from Bacillus licheniformis (Sigma-Aldrich). 
From the CGB9 incubator (deployed and collected as for CGB6 described above) 
supplemented with wheat as substrate, sequences annotated as GH57 using the 
dbCAN annotation tool (http://bcb.unl.edu/dbCAN2/); run_dbCAN.py(Zhang et al., 
2018), was provided. True amylases of the GH57 family from the dbCAN annotation 
was identified based on alignments with GH57 from Janecek and Blesak 2011 
(Janeček & Blesák, 2011). 
In courtesy from our collaborators at NMBU Ås the characterized and published 
AMOR_GH10A (Fredriksen et al., 2019) was obtained as transformed colonies and 
used as control for the plate assays.  
3. Methods  
 
3.1 Sequence analysis and selection of putative xylanase CBM9 expression 
targets  
The 34 sequences with a predicted xylanase carbohydrate binding domain were 
subjected to a set of bioinformatics analyses to provide a knowledge base for 
selection and evaluation of candidate sequences for cloning, expression, purification 
and biochemical characterization.  
3.1.1 Screening for signal peptides and transmembrane helices (TMHs) 
Signal peptides were predicted using both the SignalP5.0 
(http://www.cbs.dtu.dk/services/SignalP/) and HMMER (v2.41.1; 
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https://www.ebi.ac.uk/Tools/hmmer/search/hmmscan) webservers to find location and 
length on the sequence. Signal-P5.0 (Almagro Armenteros et al., 2019) were 
performed 3 times for each sequence, one for Gram positive, one for Gram negative 
and the final for archaea, as these sequences were of unknown prokaryote origin and 
Signal-P5.0 requires this option to be marked before it can run the prediction. It gives 
a prediction of what type of signal peptide that is present in the sequence and shows 
the cleavage site with a given probability.  
Sequences that tested negative to containing signal peptide with signal-P5.0, was 
tested with OutCyte 1.0 server (Zhao et al., 2019). This is a tool that estimates if the 
proteins contain an unconventional protein secretion system. This will help to 
distinguish if the protein is internal or exterior (secreted).  
In addition, The HMMER web server (V.2.41.1) were used for homology searches 
against the (UniPortKB) database for each sequence (Potter et al., 2018). The HMMER 
locates disorders, coiled-coil, transmembrane helix, signal peptide and protein family 
in the sequences. Each sequence without a transmembrane helix were run in the 
HMMER web tool; https://www.ebi.ac.uk/Tools/hmmer/search/phmmer. This was done 
to confirm that the sequences contained the carbohydrate binding domain, length and 
location of the domain was noted for each of the sequences.  
Finally, the online server (TMHMM 2.0), which is an online tool to predict if a protein 
sequence contains a transmembrane helix (Department of Bio and Health Informatics, 
2017, January 5), potential TMHs in the 34 target sequences were analyzed. 
 
3.1.2 Protein blast against NCBI and UniProt databases 
A functional search of the candidate protein sequences was performed with NCBI blast 
and UniProt web service to look for similar sequences based on the highest identity 
percentage value (Consortium, 2018; Coordinators, 2016). Blast against the NCBI 
database were performed with the blastp (protein-protein BLAST) algorithm (McGinnis 
& Madden, 2004). Blast results were sorted based on the highest percentage identity 
against the sequence that was tested, whereby function percentage identity and 
species was noted. The NCBI blast were run twice against two different databases. 
The first blast was done with Reference proteins (refseq_protein) database (O'Leary 
et al., 2016) performed 05.03.2020 and the second was run against the non-redundant 
protein sequences database performed 24.04.2020. Blast with the UniProt were 
performed against the UniProtKB database with 10E-threshold auto matrix with none 
filtering, this was performed 24.04.2020. Blast with UniProt were perform with the same 
protocol as the NCBI.  
 
3.1.3 Theoretical predicted melting temperature, molecular weight and isoelectric 
point 
The theoretical melting temperature of the sequences was predicted based on the 
composition of the sequences. Each candidate sequence was run in the melting 
temperature (Tm) Predictor website (http://tm.life.nthu.edu.tw/index.htm). The output 
indicates the theoretical Tm  of the protein. The predictor estimates based on three 
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categories of Tm , bellow 55 °C, between 65 to 55 °C and higher than 65 °C, 
respectively.  
Molecular weight was calculated with the online molecular weight calculation form 
(http://www.bioinformatics.org/sms2/protein_iep.html). This was performed for the 
purpose of having a potential base line to test produced protein later in the project.  
The protein Isoelectric point where determined with the Sequence Manipulation Suite 
online tool (Stothard, 2017, November 6). This tool calculates the theoretical isoelectric 
point for each protein, these values can be used to locate the proteins in a 2-D gel, and 
important when to know the pH for neutral net charge for each protein. The sequences 
were run in bulk with pK values from EMBOSS.   
3.1.4 Sequence alignment  
Global multiple sequence alignments were performed on candidate sequences without 
transmembrane helix. This was performed with the computer software MEGA-X 
(version 10.1.7) (Kumar et al., 2018). The alignment was performed using MUSCLE 
using the default options. The goal was to look for conserved regions in the sequences 
and selection of targets for expression. 
 
3.1.5 Gene construct synthesis (GenScript) 
Two CBM9 sequences were chosen to be ordered for gene synthesis at GenScript; 
CBM9_30710_4 and CBM9_302_17. To confirm that the sequences matched with 
their id, a global alignment was performed with EMBOSS NEEDLE, with an expected 
result of 100% match for both. Before running the needle alignment, the protein 
sequences need to be translated to nucleotide sequences, or translate the sequences 
sent to gene synthesis to amino acids, then aligning them in EMBOSS NEEDLE. This 
is achieved with EMBOSS Transeq (Madeira et al., 2019).The two target sequences 
were constructed with the pET-21a(+) vector with the cloning site NdeI/BamHI.  
 
3.2 Selected gene targets   
In total 9 different protein sequences were used, 8 were expressed and all were 
attempted protein purified (Table 1). Two CBM sequences with predicted xylanase 
activity were constructed for this research. 5 amylase sequences that had been 
constructed but has not been previously described before this research. One 
Neopullulanase isolated from a Geobacillus sp. performed and described in a 
previous research was further tested here (Wissuwa et al., 2016). One AMOR-
GH10A with a known activity against xylanase were used as a positive control when 
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This work  
(MH727997) AMOR-
GH10A 
pNIC-CH C terminal 
(AHHHHHH) 
(Fredriksen 





pOPINE_F C terminal 
(HHHHHH)  
(Wissuwa 
et al., 2016) 
 
3.3 Buffer preparation  
Buffer solutions for cell lysis and protein purification were prepared accordingly. 50mM 
Hepes (SIGMA-ALDRICH, St. Louis, USA), 300mM NaCl (SIGMA-ALDRICH, St. 
Louis, USA) were measured, scaled (AG64 METTLER TOLEDO) and mixed together 
with MiliQ water and 10% glycerol (SIGMA-ALDRICH, St. Louis, USA). pH was 
adjusted to 7.5. Three types of lysis buffers were prepared, for a full overview see 
(Appendix buffers)  
Binding buffer and elution buffer used for protein purification were prepared 
accordingly. Binding buffer contained 20mM Hepes (SIGMA-ALDRICH, St. Louis, 
USA) and 500mM NaCl (SIGMA-ALDRICH, St. Louis, USA). Elution buffer contained 
the same, with the addition of 500mM Imidazole (Merk, Darmstadt, Germany). 
Chemicals measured and scaled, mixed with MiliQ water and pH adjusted to 7.5. 
Number of different binding and elution buffers were prepared for this research, for a 
full overview see (Appendix buffers)  
Running buffer used for gel filtration were prepared accordingly. 20mM Hepes 
(SIGMA-ALDRICH, St. Louis, USA), 300 mM NaCl (SIGMA-ALDRICH, St. Louis, USA) 
were measured and scaled, mixed with MiliQ water and pH adjusted to 7.5.  
To reach the correct the pH level for all the buffers used, 1M HCl and 1M NaOH 
solutions were used for adjustment. The pH was measured real time with a PHM210 
standard pH meter (MeterLab, Lyon, France). All buffers were filtered with a vacuum 




3.4 Medium & plate preparation  
3.4.1 Lysogeny broth (LB) and agar plates 
LB and agar plates 10 g NaCl (SIGMA-ALDRICH, St. Louis, USA), 10 g tryptone 
(SIGMA-ALDRICH, St. Louis, USA), 5 g yeast extract (SIGMA-ALDRICH, St. Louis, 
USA). Components were measured and weighed then mixed with miliQ water to give 
the total volume a total of 1L. Autoclaved at 121°C for 20 min. Medium was cooled to 
50 °C, where 2 tablets (25 mg per tablet) of ampicillin (Novagen, Temecula, USA) were 
added. To keep the potency the ampicillin the temperature cannot exceed 50°C. 
Same procedure with agar plates with the addition of 20 g ager (SIGMA-ALDRICH, St. 
Louis, USA) per liter. After ampicillin was added, the was media poured into Petri 
dishes, 20ml in each plate. Plates were cooled for two hours without lid, to avoid 
condensation. Plates were stored with the lid, upside down at 4°C.  
 
3.4.2 Terrific broth (TB) media  
24 g yeast extract (SIGMA-ALDRICH, St. Louis, USA), 20 g tryptone (SIGMA-
ALDRICH, St. Louis, USA) and 4ml glycerol (SIGMA-ALDRICH, St. Louis, USA) mixed 
with MiliQ water for a total volume 0.9L. Autoclaved at 121°C for 20 min. 0.1L 
phosphate buffer mixed containing 0.017M KH2PO4 and 0.072M K2KPO4. Buffer filtered 
as described in buffer preparation. Buffer mixed with media after autoclavation, and 
50µg/ml kanamycin (Sigma) added.  
 
3.4.3 Starch plates  
Starch agar plate were made with phosphate buffer. 3g agar (SIGMA-ALDRICH, St. 
Louis, USA), 2g starch (SIGMA-ALDRICH, St. Louis, USA) mixed with MiliQ water to 
a volume of 100ml. Autoclaved and stored 75°C. Phosphate buffer pH 7,4 made with 
a mix of 2M solution 8,02ml K2HPO4 / 1,98 KH2PO4 and 1,17g NaCl mixed with MiliQ 
H2O for a volume 100ml. Buffer heated to 75°C and mixed with starch agar solution 
and poured into petri dishes. Cooled until solidified and stored at 4°C.  
 
3.4.4 Xylan plates  
Xylan agar plate were made with phosphate buffer. 3g agar (SIGMA-ALDRICH, St. 
Louis, USA), 2g xylan from beechwood (SIGMA-ALDRICH, St. Louis, USA) mixed with 
MiliQ H2O to a volume of 100ml. Autoclaved and stored 75°C. Phosphate buffer pH 
5,8 made with a mix of 2M solution 0,85ml K2HPO4 / 9,15 KH2PO4 and 1,17g NaCl 
mixed with MiliQ H2O for a volume 100ml. Buffer heated to 75°C and mixed with xylan 
agar solution and poured into petri dishes. Cooled until solidified and stored at 4°C.  
 
3.5 Gene construct for CBM candidate  
The two protein sequences that were chosen AMOR-CBM9-14 and AMOR-CBM9-15 
for expression was sent to GenScript (genscript.com) to construct plasmids. The signal 
peptide sequence was removed from the sequences, with additional one alanine and 
6 histidine HIS tag added on the C terminus. These were constructed in the pET-21a(+) 
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vector for each construct in the NdeI/BamHI cloning site. The pET-21a(+) vector 
contains gene for ampicillin resistance to allow for selective growth. Both proteins were 
codon optimized with GenSmartTM codon optimization Tool (genscript.com). The tool 
considers in more than 200 factors involved in gene expression including GC content 
and codon usage. The plasmids arrived as 4µg pellets in a vial.  
 
3.6 Plasmid resuspension  
Vials with vector stored at -20°C were thawed on ice, then centrifuged at 6000RPM 
fixed rotor Eppendorf (Centrifuge 5418 R, Hamburg, Germany) 1min. Resuspended 
with 80µl ultrapure water and incubated on ice for 15min, then vortexed 20 seconds, 
stored in freezer at -20°C.  
 
3.7 Transformation  
Competent cells were thawed on ice. 15µl competent cells mixed with 1µl 50 ng 
plasmid and incubated on ice for an additional 30 min. Heat shocked 20 seconds at 
42°C in a water bath (Grant SUB Aqua 5, Cambridgeshire, England) and 2 minutes 
additional incubation in ice. Cell solution was mixed with 135µl preheated 37°C SOC 
(Outgrowth Medium New England BioLabs) and incubated 37°C 200RPM in a shaker 
incubator (innova 44, New Brunswick, Canada) for 60min. 60µl and 30µl of cell mixture 
were cultured on preheated to 37°C agar plates with amp. Incubated overnight at 37°C 
upside down, then stored at 4°C. Colonies were counted for each plate to see the 
success rate of the transformation. One plate was used as a control, cultured with 
competent cells without plasmid.  
Transformation was performed with E. coli BL21-Gold (DE3) pLysS and E. coli BL21-
Gold (DE3) competent cells on AMOR-CBM9-14 and AMOR-CBM9-15. 
Transformation with E. coli BL21-Gold (DE3)competent cells performed on AMOR-
GH57 constructs and a control with empty pet21a+ vector. 
 
3.8 Expression and expression optimization  
Protocol for protein expression  
A single colony from transformed cells was picked from agar plate with a pipette and 
dropped in a 50ml falcon tube with 5ml LB + amp (100mg). Placed in shaker incubator 
(innova 44, New Brunswick, Canada), incubated overnight at 37°C 250 RPM. 
Expression culture 45ml LB + amp was inoculated with 5ml preculture. Then incubated 
at 37°C 250RPM to reach OD (optic density) between 0.6/0.8abs. OD was measured 
with UVmini-1340 spectrophotometer (SHIMADZU, Kyoto, Japan) at 600nm 
wavelength. 1ml medium was used as blank, then samples routinely measured up to 
the desired density. Each time 1ml sample placed in cuvette and ran in Uvmini. After 
OD was reached, samples were left to rest in the expression temperature 37°C 30 min. 
200µl aliquots was taken from each culture, centrifuged 13000RPM, supernatant 
removed and pellet stored at -20°C, these are used as a reference when comparing 
before and after expression. When cultures had equilibrated temperature, protein 
expression was induced with 0.1mM Isopropyl β-D-1-thiogalactopyranoside (IPTG), 
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and incubated at 37°C for 4 hours. After induction 100µl aliquots taken and treated as 
those prior to induction each hour after. Finally, expression cultures were harvested by 
centrifugation.  
 
Several attempts were made to optimize the protein expression to yield high protein 
concentration and soluble proteins, with changes to the parameters (Table 2). 
Incubation temperature affects the growth rate of the culture, and the rate of 
expression(Rosano & Ceccarelli, 2014). Testing different temperatures for the 
incubation for the preculture, expression culture and protein expression.  
When lower temperatures were tested, longer incubation time was used to assess 
slower production. Different IPTG concentrations were tested to reduce over 
expression. The amount of inoculum used to inoculate the expression culture.  
Glycylglycine has proven to have an effect on increasing solubility on some 
recombinant proteins (Ghosh et al., 2004). This was replicated with AMOR-CBM9-14 
and the AMOR-GH57 constructs. 5 cultures for each construct with 0M glycylglycine 
(Simga) 50mM glycylglycine, 200mM glycylglycine, 500mM glycylglycine and 1M 
glycylglycine in the expression culture. A total overview of the optimization steps tested 
(Table 2).  
 
Expression of AMOR-GH10A was performed as described in Fredriksen er al.’s 
article 2019(Fredriksen et al., 2019). Transformed competent cells containing AMOR-
GH10A were shipped from NMBU. Preculture made with 500ml Terrific broth (TB) 
with addition of 50 µg/ml kanamycin incubated 23°C overnight 200RPM. Expression 





Tabell 2 Overview of optimization and test in the lab for AMOR-CBM9 constructs and AMOR-GH57 constructs 
  





Expression  IPTG 
concentration 
Harvesting  Cell lysis  Sonication  




Incubation        
temp, 
RPM 
Inoculum  Temp 
and 
RPM  





(mM) Rcf and 
min  




CBM9-15                  
AMOR-
CBM9-14 
pLysS  Plate 5mL 
LB amp 








1                               
0.1* 






CBM9-15                  
AMOR-
CBM9-14 
pLysS  Plate 5mL 
LB amp 








1 4500, 10 50mM Hepes 
300mM NaCl 
10% glycerol 
(99%) pH 7.5 
 
AMOR-











1.0                           
0.037                                                         





















1.1                           
1.2                          




1 4500, 10 50mM Hepes 
300mM NaCl 
10% glycerol 




CBM9-15                  
AMOR-
CBM9-14 
Gold  Plate 3ml LB 
amp 















CBM9-15                  
AMOR-
CBM9-14 
Gold  plate 5mL 
LB amp 













pH 8.5             
50mM Hepes 
300mM NaCl          
10% 
29% 10 sec 




pH7.5     
AMOR-
CBM9-15                  
AMOR-
CBM9-14 
Gold  Plate 5mL 
LB amp 












Gold  Plate 5mL 
LB amp 






0.8 20°C ON 
150 
0.5 7000, 20 50mM Hepes 
300mM NaCl 
10% glycerol 
(99%) pH 7.5 
30% 10 sec 
* 5 
AMOR-
GH57-1     
AMOR-
GH57-2       
AMOR-
GH57-3       
AMOR-
GH57-4      
AMOR-
GH57-5 
Gold  Plate 4ml LB 
amp  




0.7                                       
0.6                                       
0.7                                       





0.3 7000, 20 50mM Hepes  
300mM NaCl 
10% glycerol 
(99%) pH 7.5 
27% 10 sec 
* 3 
AMOR-
GH57-1     
AMOR-
GH57-2       
AMOR-
GH57-3       
AMOR-
GH57-4      
AMOR-
GH57-5 
Gold  plate 3ml LB 
amp 




0.5                                       
0.5                                       
0.5                                       









29% 10 sec 





Gold  plate 3ml LB 
amp 






0.6                                       
0.5                                       
0.7                                       









29% 10 sec 
* 3  
AMOR 
CBM 9-4                  
AMOR 
CBM 9-17 

















pH 8.5             
50mM Hepes 
300mM NaCl          
10% 
Glycerol(99%) 
pH7.5     
29% 10 sec 
* 3  
AMOR 
CBM 9-4                  
AMOR 
CBM 9-17 




























0.6 37°C 4H 
200 
0.3 7000, 20 
  
AMOR-
GH57-2              
AMOR-
GH57-4       














0.3 7000, 20 
  
AMOR-
GH57-2              
AMOR-
GH57-4       




37°C 200 243 ml LB amp + 
6.25ml preculture  
37°C 
200 









29% 10 sec 
* 3  
AMOR-
GH57-2              
AMOR-
GH57-4       
Gold  Glycerol 
stock  
10ml 
LB amp  
37°C 200 97.5ml LB amp + 
2.5ml preculture  
37°C 
200 









29% 10 sec 




GH57-2              
AMOR-
GH57-4       
Gold  plate 3ml LB 
amp 
37°C 200 4ml LB amp + 
100µl preculture/         






0.7                         












GH57-2              
AMOR-
GH57-4       
Gold  plate  3ml LB 
amp             
37°C 200 4ml LB amp + 
100µl precultue/     
4ml LB amp 
(200mM 
glycylglycine) + 
100µl/                                                   
100ml LB amp + 
2.5ml precultue  
37°C 
200 
0.7                         
0.5                     
16°C ON 
200 





35% 10 sec 
* 7 
* Duplicates tested with different concentration IPTG 
** Overnight (ON) 
*** Cultures contains Glycylglycine
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3.9 Glycerol stock  
Glycerol stock was made from both the CBM9 constructs and GH57. Before induction 
of the expression culture, 150µl culture was gently mixed with 150µl glycerol 
(SIGMA-ALDRICH, St. Louis, USA) to obtain a homologues mixture and stored  at -
80°C. Two duplicates for each construct were made.  
 
3.10 Cell harvesting  
Expression cultures ready to be harvested was cooled on ice. Then poured in falcon 
tubes and centrifuged (BECKMAN COULTER Allegra 2IR, Krefeld, Germany) 
5500RPM with swingout orientation or 8000RPM fixed position 15-20min to achieve a 
solid pellet and clear supernatant. The supernatant was removed, and pellets 
weighed. Culture volume of 10ml or less was harvested at 13000RPM 5min 
(Eppendorf 5418R, Hamburg, Germany). Pellets were stored at -20°C.  
 
3.11 Cell lysis  
To retrieve the proteins, the cells had to be broken down without breaking the protein. 
Frozen pellets were thawed on ice. Then pellet was resuspended with lysis buffer  (1ml 
per 0.1g pellet) and 25 mg/l lysosome and incubated on ice 30min. Samples sonicated 
(SONICS Vibra cell VCX 130 PB, Newtown, USA) 3-5 times with 27%-29% amplitude, 
in intervals of 8-10 sec. Different variations of sonication for each sample (Table 2). 
Aliquots were taken before samples were centrifuged. 2ml samples centrifuged 
13000rpm 6 min and large samples < 2ml centrifuged 5500rpm 15-20 min.  
 
3.12 SDS-PAGE 
To test the success of the protein expression, aliquots from before induction with 
IPTG, after induction, lysed cell solution and lysed cell supernatant were tested with 
SDS-PAGE.   
Cell pellet from before induction, after induction, lysed cell solution and supernatant 
after cell lysis samples were run in SDS-PAGE gel. Pellets were resuspended in 20µl 
lysis buffer and 10µl LDS sample buffer 4x (GenScript, Piscataway, USA). 16µl lysed 
cell solution was mixed with 4µl sample buffer. 20µl supernatant was mixed with 5µl 
sample buffer. All samples were heated in a thermomixer (Eppendorf. Hamburg, 
Germany) 96°C for 10min and spun down. Each well was loaded with 16µl/40µl 
sample and a variety of different ladders were used, precision plus protein dual color 
standard (BIO-RAD, Hercules, USA) broad multi pre-stained protein standard 
(GenScript, Piscataway, USA) and elite pre-stained protein ladder (ProteinArk, 
Sheffield, England).  
Precast gels were used ExpressPlus 10%, Sure Page 12% and gradient 8-16% 
(GenScript, Piscataway, USA) placed in Mini PROTEAN Tetra cell (Bio Rad, 
Piscataway, USA). Inside between the gels and outside of the chamber surrounding 
the gels were filled with running buffer (Tris-MOPS-SDS). Gel ran 140V/170V 40/60 
min. Gels washed in ionized water then stained with instantblue (RunBlue Bis-Tris 
protein gels) 60min 160RPM shaker. Stain removed and gels distained in water over 
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night on shaker 80RPM. Gels were observed and documented on blue pad light plate 
(Bio Helix, New Taipei city, Taiwan). 
3.13 Protein purification  
Protein purification was performed with ÄKTA start (Ge Healthcare, Illinois, USA) 
protein purification system. Cell pellets were thawed on ice and resuspended with 1ml 
lysis buffer pr 0.1g cell pellet sample with addition of 0.25mg/ml lysozyme (Sigma). 
Solution incubated on ice 30min. Cells lysed with ultrasonic processor (SONICS Vibra 
cell VCX 130 PB, Newtown, USA). Total cell lysate was then centrifuged 
13000rpm/8000rpm 2-3min. Cell pellet suspension removed, and supernatant stored 
on ice. 
ÄKTA start protein purification system was prepared accordingly. Flushed with MiliQ 
H2O to remove storage ethanol 20% in the system loop. Elution buffer was then used 
to flush the loop followed by binding buffer. HisTrap column (5ml GE Healthcare) was 
then connected to the loop and flushed with binding buffer column five column 
volumes.   
Sample supernatant injected in the sample loop. Method run selected then templates 
with Affinity chromatography. With following parameters chosen: 
 
Column volume 5ml 
Flow rate 5ml/min  
Pressure limit 0.30mPA  
Sample from pump  
Sample volume 1-10mL  
Equilibration volume 5cv (column volume) 
Wash unbound volume 10-15 cv  
Elution option Gradient  
Target conc B 100% 
Gradient volume 5cv 
Fraction volume 1.5 ml 
 
Flowthrough from unbound fraction taken in purification. Elution fractions sorted from 
1-25 and stored in fridge 4°C with flowthrough. Elution fractions was tested on SDS-
PAGE gel with flowthrough, sample from cell lysate and supernatant to test if the 
protein bound to the column.  
Protein purification (Table 3) was performed as the workflow previously described with 
adjustments to each of the samples. Sample AMOR-CBM9-14, AMOR-GH57-2 and 
AMOR-GH57-4 was resuspended in lysis buffer B1 (Appendix Buffers). Sample 
AMOR-CBM9-15 was resuspended in lysis buffer B2 (Appendix Buffers). Sample 
AMOR-GH10A was resuspended in lysis buffer B3 (Appendix Buffers) without 
lysozyme. Sample 12AMOR1-GH13 was resuspended in binding buffer B9 (Appendix 
Buffers) without lysozyme. There were also used different binding and elution buffers 
with a full overview for each bellow (Table 3). Additional denatured purification was 
tested on AMOR-CBM9-14, AMOR-CBM9-15, AMOR-GH57-2 and AMOR-GH57-4 
with 8M urea (Merck) added in the binding and elution buffer.  
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Table 3 Overview of sample runs and parameters during protein purification  
Sample  Sample 
volume  
Sonication  Binding and 




1.0 ml 29% 
amplitude 10 
sec * 3 
20mM Hepes 





1.5 ml  32% 
amplitude 10 
sec * 4 
20mM NaPO4 
20mM imidazole 
500mM NaCl  
















sec * 3 
20mM Hepes 
25mM imidazole 





9 ml 35% 
amplitude 
10sec * 7 







9 ml  35% 
amplitude 
10sec * 7 
20mM Hepes 
25mM imidazole 






10 ml  35% 
amplitude 
10sec * 7 
20mM Hepes 
25mM imidazole 





10 ml  35% 
amplitude 
10sec * 7 
A: 20mM Hepes 
25mM imidazole 


















10sec * 5 
20mM NaPO4 
20mM imidazole 
500mM NaCl 8M 








10sec * 5 
20mM NaPO4 
20mM imidazole 
500mM NaCl 8M 




1.5 ml  50% 
amplitude 30 
sec * 5 
20mM NaPO4 
20mM imidazole 
500mM NaCl 8M 
urea pH 7.5  
Gradient  
AMOR-CBM9-14 
(Third run)  
1.2 ml  50% 
amplitude 30 
sec * 5 
20mM NaPO4 
20mM imidazole 
500mM NaCl 8M 




7ml  50% 
amplitude 30 










6.5 ml  50% 
amplitude 30 
sec * 5 
5mM imidazole 
50mM Tris-HCl  
500mM NaCl pH 
8  
Gradient 
*Elution buffer content is same as binding buffer with exception of 500mM imidazole, 
only binding buffer is described in the table  
A full overview of the different runs tested to purify the target protein (Table 3). The 
main difference was testing out different concentration of imidazole in the binding 
buffer.  
 
3.14 Protein dialyses  
Samples that were denatured during protein purification with urea, were attempted  
renatured with D-Tube Dialyzer Mega kit (Novagen, Darmstadt, Germany). This was 
tested on AMOR-CBM9-14 second run, AMOR-GH57-2 fifth run and AMOR-GH57-4 
fourth run (Table 3). Tubes were prepared by incubating the inner membrane with 10ml 
milli-q water for 10 minutes. AMOR-CBM9-14 elution fraction T8-12 was used, in total 
7ml sample placed D-tube, cap screwed in place and submerged in 0.4 L storage buffer 
B15 (Appendix Buffers) over night in a chilled room with a magnetic mixer. 
AMOR-GH57-2 used elution fraction T6-T12 1,4ml from each with a total 9,8ml sample. 
To remove the elution buffer with imidazole and urea from the samples D-Tube 
Dialyzer Mega kits from (Novagen) was used on proteins denatured by Urea. 6-8kDa 
tubes used. Tubes was premoisten with miliQ water, incubated 10min in room 
temperature. Then 1.4ml from each fraction from the iMac used with a total volume 
9.8ml sample in the tube. Tube was submerged in 900mL buffer and left over-night 
with a magnet stirrer. 
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AMOR-CBM9-14 that was purified with the urea buffer in the Äkta start, stored in the 
fridge 4°C in the urea buffer with imidazole. To change the buffer, the dialysis kit D-
Tube Dialyzer 10ml MWCA 6-8 kDA from Novagen used. Fraction 8 to 12 was placed 
inside the premoisten tube, total 7,5ml sample volume. The tube submerged in the new 
storage buffer 0.4L (20mM NaPO4,0.5M NaCl, 7,5pH). Placed over night in cooled 
room 4°C with magnetic stirrer. 
 
3.15 Protein concentration  
Protein samples were concentrated with Amicon® Ultra 30K device – 30,000 MWCO 
centrifugal filters (Merck, Darmstadt, Germany). New filters used for each sample and 
used according to the user guide. Filters prepared first with 4ml MiliQ water, centrifuged 
4715RPM/4000G with swing out rotor 10min. Flow through water removed and 4ml 
sample loaded. Centrifuged 4000G 15min each time more sample is loaded. Flow 
through sample retrieved and removed. Then storage buffer loaded 4ml, centrifuged 
4000G 15min, repeated 3-4 times to change the buffer in the sample. Protein sample 
is then retrieved with a pipette from the bottom of the filter. Samples kept on ice and 
stored in the fridge 4°C.  
Protein sample from the dialysis tube removed and placed in a 15ml falcon tube kept 
on ice. To increase the protein concentration Amicon Ultra centrifugal filters from Merck 
Millipore used. 3ml protein sample loaded in the tube. Centrifuged 10 min 5000RPM, 
then additional 5ml sample loaded and centrifuged 10min 5000RPM. Final volume 
200µL purified protein with 7.5mL flow trough. Tube stored in the fridge 4°C.   
 
3.16 Measuring protein concentration  
Protein concentrations were measured with Qubittm 4 Fluorometer Invitrogen by 
Thermo Fisher Scientific (Waltham, USA). Sample from before and after protein 
concentration was tested. 995µl Qbit buffer mixed with 5µl Qbit reagent was done to 
make the Qbit working solution. 3 different Qbit protein standards 10µl was mixed with 
190µl working solution. Sample mixture 5µl protein sample before and after up 
concentration with 195µl working solution. Vortex 3 sec then incubated room 
temperature 15 min. The standards measured first to obtain the standard curve. Then 
the two samples were measured after telling the Qbit how much the sample was 
diluted.   
  
3.17 Proteomics analysis of AMOR-CBM-14 
Sample from the second run from protein purification of AMOR-CBM9-14 to confirm 
the protein present on the Gel. One band from the SDS-PAGE gel of AMOR-CBM9-14 
was stapled out with x-tracta Gel Extraction (SIGMA-ALDRICH, St Louise, USA) and 
placed in sterile Eppendorf tube (2ml) and stored at -20°C. The band was delivered to 
PROBE (Proteomics Unit University of Bergen) for mass spectrometry analysis. This 




E. coli BL21 (DE3) complete genome was retrieved from NCBI (ID:167 [22818]) 
delivered along with the sequence from AMOR-CBM9-14 in a fasta file. 
 
3.18 Heat treatment  
Protein solution from AMOR-GH57-2 and AMOR-GH57-4 were tested for heat 
tolerances. 800µl of supernatant from sonication of pellets AMOR-GH57-2 and AMOR-
GH57-4, divided in two Eppendorf tubes 400µl each. Samples heated 60°C and 
70°C30min in hot well thermomixer at 60°C and 70°C. Precipitated protein removed 
with centrifuging 13000RPM 3min. Samples tested on SDS-PAGE gel with supernatant 
prior to heat treatment.  
Heat treatment was tested a second time at a later stage. Samples was taken from the 
flowthrough in the Äkta start affinity chromatography. 2ml flowthrough from AMOR-
GH57-2 and AMOR-GH57-4, expressed with and without glycylglycine. 1ml from each 
placed in hot wells 70°C and 1ml in hot wells 80°C and heated 30min. Centrifuged 
14000RPM 20min to remove precipitated proteins. Then tested on SDS-PAGE gels. 
 
3.19 Plate assay of the samples  
Concentrated purified protein was tested for activity against substrate. AMOR 
GH57_44 and AMOR-GH57-4 tested on 1% starch plate. Wells in the starch plate were 
made with pipet tip and protein loaded in each well. 2µg of protein loaded in each well 
from AMOR GH57_44, AMOR-GH57-4 and 12AMOR1-GH13. Alfa-amylase from 
Bacillus licheniformis (Sigma) used as positive control and AMOR GH10 used as 
negative control. Incubated 65°C 4 hours followed by staining with modified Gram’s 
iodine reagent (1.0 g KI, 0.5 I, 300ml H2o). The iodine stains the starch in the plate with 
a dark blue color, no staining indicates starch degradation and enzyme activity. After 
staining the results were documented and plates stored 4°C. Activity was also tested 
with 8µg protein in each well. 12AMOR1 activity was further tested for activity at 45°C, 
55°C and 60°C with 4 hours incubation time followed by staining.  
AMOR-CBM9-14 and AMOR-CBM9-15 was tested for activity on 1% xylan plate. 2 µg 
of protein loaded in wells in the plate, one from AMOR-CBM9-15 and two from AMOR-
CBM9-14 with different treatments. AMOR-GH10A used as positive control and 
12AMOR1 as negative control. Incubated 4 hours 65°C then inspected. Activity could 
be seen as clearing zones around the well, no change in color indicate no activity.  
 
3.20 Gel filtration 12AMOR1-GH13 
Gel filtration performed on 12AMOR1-GH13 with Äkta Start using HiLoad 16/600 
Superdex200pg column. Sample filtered twice, second time with standard Bio-rad Gel 
filtration standard (Table 4).  
The column was equilibrated using two column volumes of running buffer (20mM 
Hepes, 300mM NaCl, pH 7,5). Run parameter for gel filtration was 120ml column 
volume, 1ml/min flowrate, pressure limit 0.3 pascal, sample from loop, 1ml sample 




1ml 30.2 µg protein sample was first ran without standard and elution fractions 
visualized with SDS-PAGE. Second run was performed with Biorad standards (Table 
4) to estimate molecular weight. Standard was diluted with 2 ml running buffer and 400 
µl diluted standard was mixed with 200 µl (0,56mg) of protein sample, in addition to 
400 µl running buffer. 1 ml total protein sample (4.1mg) was loaded on the gel filtration 
column and run with standard parameters described above. Elution fractions with 
peaks in the chromatography was visualized using SDS-PAGE. 
 
Table 4 Gel filtration standard components  
Component Molecular weight  Amount per vial (mg)  
Thyroglobulin (bovine) 670,000 5.0 
g-globulin (bovine) 158,000 5.0 
Ovalbumin (chicken) 44,000 5.0 
Myoglobin (horse) 17,000 2.5 
Vitamin B12 1,350 0.5 
Total  18 
 
3.21 Calculation of molecular weight of 12AMOR1-GH13 from gel filtration 
chromatography  
Chromatography from gel filtration with standards was used to calculate the 
molecular weight of the sample.  With the chromatography acquired from gel filtration 
Kave was calculated for each standard, elution volume (Ve) marked by each peak and 
subtracted from the void volume (Vo) divided by the column volume (Vt) subtracted 
by void volume (Ui, 1979). Kave was plotted against log molecular weight of the 
standards in a scatter plot. Trendline was used to get the regression equation of the 







4. Results  
 
4.1 Sequence analysis and gene target selection of potential novel CBM9 
containing xylanases  
The CBM9 containing sequences were first analyzed for transmembrane helices as 
this were the first step in selecting candidates. Proteins that contain a transmembrane 
helix could be associated with the cell membrane and increase the chance for inclusion 
bodies, thus it was decided that these should not be chosen. In 8 of the CBM-
containing sequences a transmembrane helix was predicted (Table 5). A domain 
search performed with the HMMER webserver (Johnson et al., 2010) showed that most 
of the candidates contained the CBM9.1 domain (family 9 carbohydrate binding 
module), in total 8 sequences had no hit on this CBM (Table 5). Theoretical melting 
32 
 
temperature (Tm), isoelectric point (pI) and molecular weight were tested on the 
candidates. The calculated Tm indicated that the targets were thermostable. 26 CBM9 
containing sequences that did not have a predicted transmembrane helix was aligned 
in MEGA-X version (10.1.7) with the MUSCLE algorithm (Kumar et al., 2018) and 
visualized with the ESPript 3.0 web tool (Robert & Gouet, 2014). Based on the 
alignment, two candidates were chosen: AMOR-CBM9-14 and AMOR-CBM9-15 
(Figure 5). These had conserved regions similar to the other candidates, while also 
being distinctive on their own. Both sequences contained a signal peptide (Sec/SPI 
type) at the beginning of the sequences with a likelihood of 0.98 for the type and length 
(Figure 6). The signal peptide was removed from the sequences prior to vector 
construction at GenScript (genscript.com) to avoid the protein being secreted by the 
E. coli during expression. The theoretical pI was re-calculated on the AMOR-CBM9-14 
and AMOR-CBM9-15 modified sequences with his-tag and without signal peptide. The 
alteration in the sequence composition in both ends of the sequences could potentially 
alter the pI value. AMOR-CBM9-14 had theoretical pI of 8.98 and AMOR-CBM9-15 a 
pI of 6.65.  
Blast was performed in the non-redundant and uniport database, and species with the 
highest similarity was recorded for each sequence. AMOR-CBM9-14 along with 
multiple of the other CBM9 candidate sequences shared highest similarity with 
Caldithrix abyssi, which is listed in the CAZy database with a protein containing the 
CBM9 domain and 4 other CBMs (Table 5). Caldithrix abyssi is also listed in CAZy 
database with 3 family’s carbohydrate esterases, 24 families glycoside hydrolases, 12 
families glycosyltransferases and two families polysaccharide lyases. The first 
cultivated representative of the group Caldithrix abyssi originated from a deep-sea 
hydrothermal vent (Sievert et al., 2000). Bacteroidetes bacterium were dominating hit 
in the analysis with 10 sequences with highest similarity against it. Bacteroidetes 
shows hits in CAZy database, and is described with CBM50, two families for 
carbohydrate esterase, 15 families of glycoside hydrolase and 11 glycosyltransferases. 






Figure 5: Alignment of the CBM candidate sequences without transmembrane helices. Alignment performed in 





Figure 6: Sequence analysis of AMOR-CBM9-14 and AMOR-CBM9-15 revealed both contains carbohydrate 
binding module family 9 domain (CBM9) able to bind to a rage of mono and disaccharides. Signal peptide located 
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4.2 Sequence analysis of alpha amylase sequences  
Sequence analysis was performed on GH57 sequences with 12AMOR1-GH13. To 
verify that all AMOR-GH57 sequences contain the Glyco_hydro_57 domain (GH57) 
(Figure 7), domain search was performed with HMMER webserver (Johnson et al., 
2010). No predicted signal peptide found on the N terminal, so one additional analysis 
was performed with OutCyte (Zhao et al., 2019) to predict if the sequences contained 
an unconventional protein secretion system (UPS) (Table 6). AMOR-GH57-2 and 
AMOR-GH57-4 were categorized as UPS, indicating that they might have a system for 
protein secretion without the use of conventional signal peptide. The sequences were 
thermostable, and AMOR-GH57-4 had a predicted thermostability higher than 65 °C 
based on (Tm) calculated. The pI varied between 5.2 to 8.2 between the GH57 
sequences (Table 6). Blast with NCBI non-redundant database and uniport revealed 
that the five alpha-amylase sequences all had similarity around 80% with proteins from 
archaea. There was no dominating similarity in the blast results, AMOR-GH57-1, 
AMOR-GH57-4 and AMOR-GH57-5 had similarity with proteins from archaea phyla 
Euryarchaeota. AMOR-GH57-1 with hit against Thermoplasmata archaeon and 
AMOR-GH57-5 with hit against Methanosarcinales archaeon are both described in the 
CAZy database with a GH57 module. Thermoplasmata archaeon also has a 
Glycosyltransferase family. Methanosarcinales archaeon is also described with two 
CBM families, 8 different glycosyl hydrolase, 8 glycosyltransferase and one 
polysaccharide lyases.  
 
Figure 7: Sequence analysis of the five α-amylase sequences. All the sequences contain the Glyco_hydro_57 





Table 6 Sequence analysis of the GH57 containing sequences and 12AMOR1-GH13 
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4.3 Transformation of samples  
Transformation was performed with the same procedure on all the constructs using 
competent cells without plasmids as controls. Growth of visible colonies on the agar 
plates containing ampicillin indicates that the E. coli has successfully taken the pET-
21a plasmid containing both the construct sequence and ampicillin resistance (Figure 
8). The control plates with competent cells that had not been transformed showed no 
growth, indicating that the selective media only support growth for those cells that have 
taken the plasmid. Both BL21 Gold and BL21 pLysS competent cells were successful 
in the transformation, but comparing the plates and number of colonies, the amount 
was much greater with pLysS then with Gold (Table 7). While the colonies were much 
smaller and more difficult to count those with pLysS.  
 
 
Figure 8: Overview of the different transformations performed cultured on agar plates containing ampicillin. A) 
transformation of E. coli BL21-Gold (DE3) pLysS competent cells with AMOR-CBM9-15, B) transformation of E. coli 
BL21-Gold (DE3) competent cells with AMOR-CBM9-14, C) transformation of E. coli BL21-Gold (DE3) cells with 
AMOR-GH57-4, D) positive control with pet21a plasmids in E. coli BL21-Gold (DE3) cells, and E) negative control 
used for each transformation using competent cells that has not been transformed with a plasmid.  
 
Table 7 Overview of the E. coli BL21-Gold (DE3) pLysS and E. coli BL21-Gold (DE3) 
competent cell transformations.  
Working name and 
competent cell 
Number of colonies 60µL Number of colonies 30µL 
AMOR-CBM9-15 (pLysS) 1314 660 
AMOR-CBM9-14 (pLysS) 1322 678 
AMOR-CBM9-15 (Gold) 114 33 
AMOR-CBM9-14 (Gold) 149 79 
AMOR-CBM9-15 (Gold) 206 431 
41 
 
AMOR-CBM9-14 (Gold) 81 26 
AMOR-GH57-3 (Gold) 166 104 
AMOR-GH57-5 (Gold) 268 242 
AMOR-GH57-1 (Gold) 120 76 
AMOR-GH57-2 (Gold) 221 127 
AMOR-GH57-4 (Gold) 714 278 
Pet21a+ (Gold) (both 60µl) 339 229 
 
4.4 Expression of CBM9 containing constructs  
Expression of AMOR-CBM9-15 and AMOR CBM9-14 was achieved with both E. coli 
BL21-Gold (DE3) pLysS and BL21-Gold (DE3) competent cells (Figure 9-10). The 
major difference between pLysS and Gold was the time it took to achieve optical 
density. Gold had a stable predictable growth and achieving an OD600nm of 0,6/0,8 2 
hours after inoculation with 10% preculture or 3 hours with 2.5% inoculum. In 
comparison, pLysS with 10% inoculum used 4 to 6 hours reaching desired density. 
Hence, the E. coli BL21-Gold competent cells were selected as expression host. 
A series of expression parameters was tested during protein expression to increase 
the success for soluble proteins for the two selected AMOR-CBM9 targets. In addition 
to standard conditions at 37°C 4 hours, lowering the incubation temperature to 20°C 
and 16°C overnight was performed. These growth conditions were performed to see 
the effect on expression levels and the effect on potential soluble proteins. The 
optimization tests showed that expression at 20°C overnight was the lowest 
temperature with detected expression of target proteins, even if increasing the IPTG 
concentration from 0,1mM to 0,2mM at 16°C overnight. Visible expression on SDS-
PAGE was seen on cultures tested between 20°C and 37°C, glycylglycine had no 
effect on solubility (Figure 11), while 16°C was tested twice with no visible expression 
of the target protein. AMOR-CBM9-15 had a theoretical pI of 6.65, and was tested with 
lysis buffers of different pH; 7.5, pH 8 and pH 8.5, to try and stabilize the protein in the 




Figure 9: SDS-PAGE of AMOR-CBM9-15 and AMOR-CBM9-14 expressed with E. coli BL21-Gold (DE3) pLysS 
competent cells. Samples separated on GenScript ExpressPluss PAGE Gels 10%. Target protein expressed is 
highlighted with black boxes around the bands. M (marker); BIO-RAD precision plus protein dual color standards, 
B (before induction); fraction before expression, I (induced); fraction taken each hour (H) after expression was 







Figure 10: SDS-PAGE of AMOR-CBM9-15 and AMOR-CBM9-14 expressed with E. coli BL21-Gold (DE3) 
competent cells. Samples separated on GenScript ExpressPluss PAGE Gels 10%. The target protein is 
highlighted with a black box around the bands. M (marker); GenScript broad multi pre-stained protein standards, 
B (before induction); fraction before expression, I (induced) fraction taken each hour (H) after expression was 
induced, L (lysate); fraction harvested and sonicated, S (soluble); fraction separated from lysate. Expression was 
performed 37°C 4 hours.  
 
 
Figure 11: SDS-PAGE of AMOR-CBM9-14 expressed with Glycylglycine in E. coli BL21-Gold (DE3) competent 
cells. Samples separated on GenScript ExpressPluss PAGE Gels 10%. The target protein is highlighted with a 
black box around the bands. M (marker); GenScript broad multi pre-stained protein standards, G (glycylglycine); 
added in 4 different cultures, ranging from 50mM to 1M, B (before induction); fraction of expression, L (lysate); 





4.5 Purification of CBM9-containing constructs  
The first attempt on purifying the AMOR-CBM9-14 showed promising result on the 
chromatography from the Äkta start with a good peak between elution fraction T5 to 
T17 (Figure 12.A). When tested on SDS-PAGE there was several different bands with 
varying size in the observed chromatography peak, with the band at 50 kDa the most 
abundant (Figure 12.B). Since the target protein has a theoretical molecular weight of 
82 kDa, this indicated that observed bands are E. coli host proteins. Hence, the 
purification of AMOR-CBM9-14 was not successfully. 
A second run on purifying the AMOR-CBM9-14 was initiated by modifying the elution 
buffer and binding buffer with 20mM imidazole and 8M urea (Figure 13). The protein 
sample was applied to the His-trap column directly from the cell lysate to avoid losing 
the target protein due to aggregation in the solubilization step. The addition of 
imidazole and urea would denature and avoid E. coli protein binding to the His-trap 
column. Although also denaturing the target protein, this was an effort to increase the 
possibility that AMOR-CBM9-14 bind to the His-trap column, and subsequently 
renatured by removing the imidazole and urea by changing the buffer. The 
chromatography showed a very low peak during the elution process (Figure 13.A). This 
was compared on an SDS-PAGE gel with proteins from an uninduced sample, the cell 
lysate, and the soluble fraction from induced cells, which resulted in a single band from 
T6 to T14 (Figure 13.B). To confirm that this was the AMOR-CBM9-14 target protein, 
the band was cut from the gel and sent to the Proteomics unit at UIB (PROBE; 
https://www.uib.no/rg/probe). The mass spectrometry results from PROBE confirmed 
the presence of AMOR-CBM9-14 and thus, successfully purified (Appendix Proteomic 
analysis). As a result, denaturation with the addition of imidazole and urea directly to 
the cell lysate showed promise in the process of purifying the protein compared to the 
result with the standard protocol.  
The third purification run of AMOR-CBM9-14 and the first purification of AMOR-CBM9-
15 were adjustments of the second run of AMOR-CBM9-14. Sonicated lysate samples 
were resuspended in binding buffer B7 (Appendix Buffers), vortexed to mix the 
solution, and then applied to the His-trap column. The first purification of AMOR-CBM9-
15 showed a small elution peak between fraction T7-T13 and bands of similar size as 
aliquot taken from the cell lysate (Figure 14.A). Bands in the flowthrough showed that 
the sample only obtained a partly binding to the column and some of the proteins were 
washed out (Figure 14.B). The third purification of AMOR-CBM9-14 had similar results 
as the first purification of AMOR-CBM9-15, with a small elution peak between fraction 
T7-T13 and weak bands on the SDS-PAGE that was also present in the flowthrough 
fraction (Figure 15). The eluted fractions, T7-T13, for AMOR-CBM9-15 and AMOR-
CBM9-14 (Figure 14-15) was collected and concentrated with Amicon ultra centrifugal 




Figure 12: First purification of AMOR-CBM9-14 using a His-trap column. A) chromatography from Äkta start with 
the unbound flowthrough peak (36-54 ml) and elution peak (T1-T18), B) SDS-PAGE with elution fractions (T), 





Figure 13: Second purification of AMOR-CBM9-14 using a His-trap column. A) chromatography from Äkta start 
with the unbound flowthrough peak (36-52 ml) and elution peak (T5-T15), B) SDS-PAGE with elution fractions (T6-
T14), M (marker); GenScript broad multi pre-stained protein standard, B (before induction); fraction of expression, 
L (lysate); harvested and sonicated fraction, S (soluble) fraction separated from lysate. Samples was separated on 




Figure 14: First purification of AMOR-CBM-15 using a His-trap column. A) chromatography from Äkta start with 
the unbound flowthrough peak (36-48 ml) and elution peak (T7-T25), B) SDS-PAGE with elution fractions (T7-
T13), L (lysate); harvested and sonicated sample, S (soluble); fraction separated from lysate, FT (flow through); 
unbound fraction, T (elution peak); containing all fraction within the peak, P (protein); elution peak concentrated 
with centrifugal filtration, M (marker); GenScript broad multi pre-stained protein standard. Samples separated on 
(GenScript SurePage, Bis-Tris 8-16%), protein mass calculated from protein concentration and amount loaded. 





Figure 15: Third purification of AMOR-CBM9-14 using a His-trap column. A) chromatography from Äkta start with 
the unbound flowthrough peak (36-54 ml) and elution peak (T7-T13), B) SDS-PAGE with elution fractions (T7-T13), 
L (lysate); harvested and sonicated sample, S (soluble); fraction separated from lysate, FT (flow through); unbound 
fraction, T (elution peak); containing all fraction within the peak, P (protein); elution peak concentrated with 
centrifugal filtration, P* (protein) from second purification included for comparison, M (marker); GenScript broad 
multi pre-stained protein standard. Samples separated on (GenScript SurePage, Bis-Tris 8-16%), protein mass 





The control xylanase characterized in Fredriksen et al. (Fredriksen et al., 2019). 
AMOR-GH10A, was purified during the first run (Figure 16). With a large band in the 
soluble fraction, no modification was done to the purification process (Figure 16.B). 
From the chromatography the protein was eluted between fraction T7 to T25 (Figure 
16.A). Fraction T9 to T16 was collected for concentration with the Amicon ultra-4 
centrifugal filters. These fractions were chosen since they had the highest absorbance 
indicating that these contained most of the protein. Elution fractions were tested on 
SDS-PAGE with samples from the cell lysate, soluble fraction and flowthrough (Figure 
16.B). The flowthrough fraction showed that most of the protein bind to the column 
while present in all the elution fraction T9 to T16. During the protein concentration, the 
buffer was changed from the elution buffers to a storage buffer B16 (Appendix Buffers). 





Figure 16: Purified AMOR-GH10A using a His-trap column. A) chromatography from Äkta start with the unbound 
flowthrough peak (36-72 ml) and elution peak (T7-T25), B) SDS-PAGE with elution fractions (T9-T16), L (lysate); 
harvested and sonicated sample, S (soluble); fraction separated from lysate, FT (flow through); unbound fraction, 
T (elution peak); containing all fraction within the peak, P (protein); elution peak concentrated with centrifugal 
filtration, M (marker); GenScript broad multi pre-stained protein standard. Samples separated on (GenScript 
SurePage, Bis-Tris 8-16%), protein mass calculated from protein concentration and amount loaded. The target 





4.6 Plate assay for enzyme xylanase activity  
Enzyme activity was tested on agar plates containing 1% xylan (Figure 17). 2µg of 
purified protein of AMOR-CBM9-14 (second and third purification) and AMOR-CBM9-
15 (first purification) was used for the agar plate assay. The purified AMOR-GH10A 
xylanase was used as a positive control and the purified 12AMOR1-GH13 amylase 
was used as a negative control. After incubation at 65°C for 4 hours, the plate was 
inspected for clearing zones around the wells. The positive control, AMOR-GH10A, 
showed a visible clearance zone around the well, indicating activity for xylan 
degradation (Figure 17, nr .1). In comparison, the purified target enzymes, AMOR-
CBM9-14 and AMOR-CBM9-15 (Figure 17, nr.3-5), and the negative GH13 control 
(Figure 17, nr.2), showed no indication of activity with the absence of discoloration 
around the wells on the plate.  
 
 
Figure 17: Plate assay on agar plates containing 1% xylan and phosphate buffer pH 5.8 loaded with 2µg protein in 
each well and incubated 65°C 4H. 1 positive control AMOR-GH10A. 2 negative control 12AMOR1-GH13. AMOR-
CBM9-14 second run. AMOR-CBM9-14 third run. AMOR-CBM9-15.   
 
4.7 Expression of -amylase constructs  
The five α-amylase constructs were first tested with expression at 20°C overnight. 
Expression was visible on lysate fraction for all the constructs. A second try was done 
with expression at 16°C overnight with the successful expression of all five constructs 
(Figure 18-19). In addition, AMOR-GH57-2 showed a band in the supernatant (S), 




Figure 18 SDS-PAGE of AMOR-GH57-1, AMOR-GH57-2 and AMOR-GH57-3 expressed with E. coli BL21-Gold 
(DE3) competent cells. Samples separated on (GenScript ExpressPlus 10%), M (marker); GenScript broad multi 
pre-stained protein standards, B (before induction); fraction before expression, L (lysate); harvested and 
sonicated samples, S (soluble); fraction separated from lysate. Target proteins expressed is highlighted with black 




Figure 19 SDS-PAGE of AMOR-GH57-4, AMOR-GH57-5 and pET-21a control expressed with E. coli BL21-Gold 
(DE3) competent cells. Samples separated on (GenScript ExpressPlus 10%), M (marker); GenScript broad multi 
pre-stained protein standards, B (before induction); fraction before expression, L (lysate); harvested and 
sonicated samples, S (soluble); fraction separated from lysate. Target proteins expressed is highlighted with black 
boxes around the bands. Expression was performed 16°C overnight.   
 
In order to enhance the solubility of AMOR-GH57-4 during expression, glycylglycine 
was tested to enhance solubility, concentration of (0-1M) was added in the expression 
media. When comparing proteins in lanes before induction (Figure 20.(B)), with 
proteins in the cell lysate (L) and soluble (S) of AMOR-GH57-4, the target protein is 
visible in the both the cell lysate and supernatant (Figure 20). Thus, indicating that the 
target protein is expressed and soluble, respectively. Furthermore, the addition of 
glycylglycine also had an effect on the growth of the cultures. Cultures with 0M and 
50mM glycylglycine reach target optical density (OD) of 0.6-0.8 600nm after 4 hours, 
while the addition of 200mM glycylglycine used 5 hours and 0.5M glycylglycine used 
6.5 hours. 1M glycylglycine grew very slowly and was induced after 6.5 hours at an OD 
of 0.24 600nm.  
54 
 
Figure 20 SDS-PAGE of AMOR-GH57-4 expressed with E. coli BL21-Gold (DE3) competent cells with the addition 
of glycylglycine. Samples separated on (GenScript ExpressPlus 10%), M (marker); GenScript broad multi pre-
stained protein standards, B (before induction); fraction before expression, L (lysate); harvested and sonicated 
samples, S (soluble); fraction separated from lysate, G (glycylglycine) added in expression culture ranging from 
50mM to 1M concentration. Target proteins expressed is highlighted with black boxes around the bands. Expression 
was performed 16°C overnight.  
 
The addition of glycylglycine to the growth media was also tested for the 4 other GH57 
target proteins, however limited to 0M, 50mM and 200mM glycylglycine due to the 
reduced growth rate of the expression host at higher concentrations. AMOR-GH57-2 
got similar results as AMOR-GH57-4 with the band visible in the cell lysate and soluble 




Figure 21: SDS-PAGE of AMOR-GH57-2 expressed with E. coli BL21-Gold (DE3) competent cells with the addition 
of glycylglycine. Samples separated on (GenScript ExpressPlus 10%), M (marker); GenScript broad multi pre-
stained protein standards, B (before induction); fraction before expression, L (lysate); harvested and sonicated 
samples, S (soluble); fraction separated from lysate, G (glycylglycine) added in expression culture ranging from 
50mM to 200mM concentration. Target proteins expressed is highlighted with black box around the bands. 
Expression was performed 16°C overnight.  
 
4.8 Purification of GH57 and GH13 -amylases   
The AMOR-GH57-2 and AMOR-GH57-4 was subjected to heat treatment to test if the 
target proteins would not precipitate and could be used as an additional purification 
step (Figure 22). The first heat treatment at 60°C and 70°C was not conclusive since 
the SDS-PAGE gel showed bands drifting between the wells. A second attempt for 
each construct was performed with 1ml of flowthrough from protein purification for 
30min at 70°C and 80°C and compared to a supernatant that was not heat treated. 
Results showed heat treatment precipitated both E. coli proteins and both AMOR-




Figure 22 SDS-PAGE of heat-treated AMOR-GH57-2 and AMOR-GH57-4. Protein samples heated 30 min in 
thermomixer, tested at (70°C) and (80°C), G (glycylglycine); samples expressed with 200mM glycylglycine, S 
(sample) unbound flowthrough fraction from protein purification, M (marker) GenScript broad multi pre-stained 
protein standards. Samples separated on (GenScript SurePage, Bis-Tris 8-16%), precipitated protein were removed 
by centrifugation before loading on gel.  
Both AMOR-GH57-2 and AMOR-GH57-4 were chosen to be purified since these had 
the largest bands in the soluble supernatant fraction after expression. First purification 
was done with samples that was expressed with 200mM glycylglycine at 16°C 
overnight. The binding buffer was modified with 25mM imidazole to avoid E. coli 
proteins to bind to the column. The first purification for both samples showed no visible 
elution on the chromatography and no visible bands on the SDS-PAGE. Inspecting the 
flowthrough fraction, showed that the protein did not bind to the his-trap column. The 
purification was re-run under identical conditions to test if there was a user error, 
however, the result was identical with no protein binding the his-trap column. A third 
purification was performed from cells expressed without glycylglycine to test if this 
prevented binding to the column. Both AMOR-GH57-2 and AMOR-GH57-4 was 
washed out with the flowthrough with no difference in results against samples with 
glycylglycine. The flowthrough from AMOR-GH57-4 third run was diluted in binding 
buffer without imidazole, with a total concentration of 10mM imidazole in the sample. 
Then purified again as fourth run with binding buffer contain 10mM imidazole and a 
flowrate at 2ml/min. However, similar results were observed, with the target protein 
washed out in the flowthrough with the unbound E. coli proteins. 
Purification of denatured target proteins was then tested using binding and elution 
buffers containing 8M urea. AMOR-GH57-2 had a small elution peak in the 




Figure 23: Fifth run purifying AMOR-GH57-2 using a His-trap column. A) chromatography from Äkta start with the 
unbound flowthrough peak (36-54 ml) and elution peak (T6-T15), B) SDS-PAGE with elution fractions (T9-T16), L 
(lysate); harvested and sonicated sample, S (soluble); fraction separated from lysate, FT (flow through); unbound 
fraction, T (elution peak); containing all fraction within the peak, P (protein); elution peak concentrated with 
centrifugal filtration, M (marker); GenScript broad multi pre-stained protein standard. Samples separated on 
(GenScript SurePage, Bis-Tris 8-16%), protein mass calculated from protein concentration and amount loaded. 






However, the target protein, AMOR-GH57-2, as determined by size, was also present 
in the flowthrough (Figure 23.B). Hence, partly binding to the column. AMOR-GH57-4 
had similar results with a small elution peak with two weak bands T11 and T13, and 
presence in flowthrough fraction (Figure 24).  
 
Figure 24: Fourth run purifying AMOR-GH57-4 using a His-trap column. A) chromatography from Äkta start with 
the unbound flowthrough peak (36-72 ml) and elution peak (T8-T18), B) SDS-PAGE with elution fractions (T9-T16), 
L (lysate); harvested and sonicated sample, S (soluble); fraction separated from lysate, FT (flow through); unbound 
fraction, T (elution peak); containing all fraction within the peak, P (protein); elution peak concentrated with 
centrifugal filtration, M (marker); GenScript broad multi pre-stained protein standard. Samples separated on 
(GenScript SurePage, Bis-Tris 8-16%), protein mass calculated from protein concentration and amount loaded. 




AMOR-GH57-2 and AMOR-GH57-4 were renatured with protein dialysis overnight and 
concentrated with centrifugal filtration, resulting in 200µl of AMOR-GH57-2 with a 
concentration of 102µg/ml and 200µl of AMOR-GH57-4 with a concentration of 
122µg/ml.  
The control amylase 12AMOR1-GH13 was purified as previously described in 
Wissuwa et al. (Wissuwa et al., 2016), using an additional heat treatment step on the 
cell lysate which removed some of the E. coli proteins in the sample and not effecting 
the target protein (Figure 25). Although a weak band was observed in the flowthrough 
at 65kDa, most of the GH13 protein bound to the column. After centrifugal filtration, 






Figure 25: Purified 12AMOR1-GH13 using a His-trap column. A) chromatography from Äkta start with the unbound 
flowthrough peak (36-72 ml) and elution peak (T7-T25), B) SDS-PAGE with elution fractions (T9-T16), L (lysate); 
harvested and sonicated sample, S (soluble); fraction separated from lysate, FT (flow through); unbound fraction, 
T (elution peak); containing all fraction within the peak, P (protein); elution peak concentrated with centrifugal 
filtration, M (marker); GenScript broad multi pre-stained protein standard. Samples separated on (GenScript 
SurePage, Bis-Tris 8-16%), protein mass calculated from protein concentration and amount loaded. Target protein 





4.9 Gel filtration and molecular weight calculation of 12AMOR1-GH13 
Gel filtration of 12AMOR1-GH13 without standards showed that the protein sample 
from the purification contained low contamination. During gel filtration, a small amount 
of a larger protein was eluted before 12AMOR1-GH13 as seen in the chromatogram 
(Figure 26.A).  
 
Figure 26 Gel filtration of 12AMOR1-GH13 without standards. A) chromatogram from Äkta start with HiLoad 16/600 
Superdex200pg column, with exclusion peak (T17-T19). SDS-PAGE with exclusion fractions (T14-T20), Ps (protein 
sample); purified with His-trap column and concentrated, T14-T20 (exclusion fractions);from gel filtration, M 
(marker); GenScript broad multi pre-stained protein standard. Samples separated on (GenScript SurePage, Bis-




Fraction T17 and T18 was then concentrated with ultra-centrifugation. To calculate the 
molecular weight of 12AMOR1-GH13, a second gel filtration was performed spiked 
with standards (Bio-Rad). Chromatography was used to calculate the elution volume 
of the standards to get Kave values (Figure 27.A).  
 
 
Figure 27: Gel filtration of 12AMOR1-GH13 standards (BioRad). A) chromatogram from Äkta start with HiLoad 
16/600 Superdex200pg column, with exclusion peak (T11-T29). SDS-PAGE with exclusion fractions (T14-T20), Ps 
(protein sample); purified with His-trap column and protein standards, T13-T29 (exclusion fractions); from gel 
filtration, M (marker); GenScript broad multi pre-stained protein standard. Samples separated on (GenScript 




These values were plotted in a scatter plot with log of the molecular weights of the 
protein standards. The trendline was further used to calculate the molecular weight of 
12AMOR1-GH13 (Appendix Gel filtration scatter plot). The molecular weight was 
estimated to be 105.5 kDa. The oligomeric state of 12AMOR1-GH13 is estimated to 
a dimer, as native state is almost double of the denatured state.   
 
4.10 Plate assay for -amylase activity 
The purified protein from denaturation purification of AMOR-GH57-2 and AMOR-
GH57-4 was tested with 12AMOR1-GH13 for activity on agar plates containing 1% 
starch, using -amylase from Bacillus lichenifromis (SIGMA-ALDRICH, St Louis, USA) 
as positive control and AMOR-GH10A as a negative control (Figure 28). 2µg of each 
purified protein was loaded in each well on the agar plate and incubated for 4 hours 
65°C and subsequently stained with an iodin mixture (1g KI, 0.5g I, 300ml H2O). A 
clearance zone observed around the positive control and 12AMOR1-GH13 showed 
that the starch had been degraded (Figure 28). 
 
Figure 28: Agar plate with 1% starch and phosphate buffer pH 7.4. 2µg protein loaded in each well and incubated 
for 4 hours before staining with iodine solution. 1) Bacillus licheniformis -amylase from Sigma as positive control. 
2) AMOR-GH10A xylanase as negative control. 3) 12AMOR1-GH13. 4) AMOR-GH57-4. 5) AMOR-GH57-2. A: 
incubated at 65°C. B: incubated at 60°C. C: incubated 55°C. D: incubated at 45°C.  
 
Even after storing 12AMOR1-GH13 in the fridge at 4°C the clearance zone increased 
in size, indicating activity at low temperature. 12AMOR1-GH13 was also tested at 
60°C, 55°C and 45°C for 4 hours (Figure 28.B,C and D). The results show that 
12AMOR1-GH13 has activity on starch in the temperature range 65°C to 45°C. AMOR-







5. Discussion  
 
5.1 Sequenced-based analysis of selected CAZYmes 
Sequence’s analysis was performed to examine for thermostability, signal peptide and 
transmembrane helices. This was done to narrow down the candidate selection for 
expression on the CBM9 containing sequences. Blast results for CBM9 containing 
sequences (Table 5) showed that Bacteroidetes bacterium and Caldithrix abyssi were 
the dominating hits. Both have been described as part of the biodiversity in 
hydrothermal vents (Fedosov et al., 2006; Gavande et al., 2021). Both are also listed 
in the CAZy database with multiple GH families (Lombard et al., 2014), expected with 
the annotation of these CBM9 containing sequences. 
Sequence analysis revealed that the GH57 sequences contained the Glycoside 
hydrolase class without a carbohydrate binding module present. Cazy enzymes does 
not need a CBM to function, while shows that these helps to increase the activity with 
binding to substrate and can affect the thermostability. CBMs can be 30 to 200 amino 
acids in size and up to 3 CBMs on one protein (Shoseyov et al., 2006). 
Homology blast of GH57 sequences showed that three of the sequences had similarity 
to proteins from the Euryarchaeota phyla. AMOR-GH57-2 is related to the 
superphylum DPANN and AMOR-GH57-3 to the superphylum TACK (Dombrowski et 
al., 2019; Guy & Ettema, 2011). Euryarchaeota has been reported from hydrothermal 
vents with CAZymes activity (Li et al., 2015). These results fit with the assumption of 
thermophilic origin, as many of the hits have been found at hydrothermal vents.  
 
5.2 Novel CBM9 xylanases at AMOR? 
CBM9 is associated with xylanases showing endo-1,4-β-xylanase activity (EC 3.2.1.8), 
and to date this activity is found in the following GH families (3, 5, 6, 8, 9, 10, 11, 16, 
18, 26, 30, 43, 51, 62, 98 and 141, http://www.cazy.org/). The primary sequence of 
CBM9 comprises 170 residues and found primarily in xylanases, with one cellulose-
binding function detected so far (Lombard et al., 2014).  Here we expect the CBM9 
containing sequences to have a putative xylanase activity based on the CBM9 domain. 
To test this, two sequences were expressed, purified and tested for activity on plates 
containing xylan. AMOR-CBM9-14 and AMOR-CBM9-15 were both successfully 
expressed in both BL21 DE3 Gold and pLysS competent cells in the temperature range 
of 20°C to 37°C. BL21 DE3 Gold were chosen for further expression due to a faster 
growth rate. Expression was tested twice at 16°C, including an increase in IPTG 
concentration to 0.2 mM, with no observed expression. For the CBM9 target genes 
induction at 20°C was the lowest temperature for observed expression. Performing 
expression at lower temperatures has previously been shown to promote solubility by 
decreasing the amount of produced proteins (Schein & Noteborn, 1988).  
65 
 
To overcome insoluble protein aggregates of the CBM9 proteins, expression was 
performed with the dipeptide glycylglycine added in the media. This approach was 
inspired by a paper published on the effect of glycylglycine on soluble proteins (Ghosh 
et al., 2004). However, no yield of soluble protein was observed after expression of 
AMOR-CBM9-14 (Figure 11). A major difference with AMOR-CBM9-14 and AMOR-
CBM9-15, compared to the work by Ghosh et al., was insoluble proteins after 
expression. Hence, enhancing the solubility with the addition of glycylglycine may only 
be successful if the target protein is partly soluble. Furthermore, AMOR-CBM9-15 was 
also tested with 3 different lysis buffers with the pH range 7.5 – 8.5 with no effect.   
After different attempts on optimizing the expression of both AMOR-CBM9-14 and 
AMOR-CBM9-15 to obtain soluble protein with no result, attempts to purify the samples 
were performed. Although having insoluble proteins as visualized on gels, an attempt 
on purifying with a his-trap column was performed on AMOR-CBM9-14. The result 
showed a mix of proteins with the most abundant around 50kDa in fraction T12-T16 
from the elution peak (Figure 12). Since AMOR-CBM9-14 is expected to be 82 kDa, 
this indicated that the column showed unspecific binding to E. coli proteins and not the 
target. Since AMOR-CBM9-14 was not expressed as a soluble protein, we assume 
that the expressed target proteins aggregated as inclusion bodies inside the cell. This 
is not an uncommon occurrence in heterologous protein expression (Rosano & 
Ceccarelli, 2014) and one of the largest obstacles in biotechnology. One approach, 
dating back to 1961, in a study by Anfinsen and Haber (Anfinsen & Haber, 1961), is 
the addition of the denaturing agent urea in the binding and elution buffer, introducing 
reversible denaturation of proteins. Using urea as denaturing agent in the cell lysate 
after expression resulted in the successful purification of a denatured AMOR-CBM9-
14, (Figure 13), confirmed by mass spectrometry at the proteomics unit, UiB. Similar 
results were obtained for AMOR-CBM9-15 (Figure 14). Renaturing of both targets 
followed the procedure of the control AMOR-GH10A.  Since the control originates from 
the same metagenome as the target CBM9 proteins, these conditions might be better 
suited.  
When proteins are expressed but not soluble in heterologous protein expression, it 
becomes a bottleneck for further analysis. Similar studies done on a larger scale with 
506 CAZymes from procaryotic origin, resulted in 323 soluble proteins (Helbert et al., 
2019). In the current study, lowering the expression rate by adjusting the IPTG inducer 
concentration, in two different strains of competent E. coli was performed to overcome 
this obstacle. Furthermore, codon optimization was performed with GenScript 
GenSmart tool to limit the possibility for codon bias when expressed in E. coli. Another 
approach on synthesized genes would be codon harmonization. This is a method  
which aims to replicate the codon usage frequencies with the expression host (Punde 
et al., 2019). This allows the expression to be similar to the origin organisms. To 
achieve codon optimization on AMOR-CBM9-14 and AMOR-CBM9-15 a profile could 
be made based on the metagenome-assembled genomes (MAG) from which the target 
enzymes belong. Thus, obtaining a profile to match the codon frequency to the 
expression host and optimizing protein expression and folding.  
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Other strategies that have proven successful in heterologous protein expression is the 
use of fusion proteins (Rosano & Ceccarelli, 2014). A study of a thermophilic 
cyclomaltodextrinase, showed that optimized expression increased the solubility in 
connection with the NusA fusion protein,  and activity increased with the fusion protein 
cleaved of (Turner et al., 2005). Helbert et al (Helbert et al., 2019) tested 24 of the 
insoluble proteins with 4 fusion proteins, DsbC, thioredoxin, maltode-binding protein 
and CpB, without achieving solubility. Fusion proteins are not a guaranty for obtaining 
solubility during protein expression, however, could be helpful as part of the expression 
toolbox. Selecting the right fusion partner when testing is also something to consider 
as they vary in size and can affect the protein differently (Costa et al., 2014). 
 
5.3 Difficulties working with GH57 amylase sequences 
The GH57 candidates AMOR-GH57-2 and AMOR-GH57-4 showed the largest soluble 
fraction after protein expression at 16°C overnight and were chosen to be purified with 
the His-trap column. Similar to the CBM9 targets, all of the GH57 target proteins were  
expressed using glycylglycine to enhance the amount of soluble protein. Overall, 
glycylglycine enhanced the solubility of GH57 target proteins (Figure 20 and 21), 
however, using 1M glycylglycine showed a negative effect on the growth rate of the 
host, increasing the time to reach desired optical density for induction. 
Assessing if there was an increase in the amount of soluble protein with increasing 
glycylglycine concentration were difficult based on the SDS-PAGE gels alone. The 
study which described the increase in soluble protein with glycylglycine, concluded that 
1M glycylglycine yielded the highest amount of soluble fraction (Ghosh et al., 2004). 
However, the major difference from the current study was that the glycylglycine 
experiments were not performed with terrific broth media, which could have solved or 
reduced the growth limitation caused by the increase of glycylglycine.  
The first purifications of AMOR-GH57-2 and AMOR-GH57-4 were performed on 
cultures expressed with 200mM glycylglycine, with no visible protein bound to the His-
trap column and that were washed out with the flowthrough fraction. To check if the 
glycylglycine influenced binding to the His-trap column, the purification was repeated 
with samples expressed without glycylglycine.  However, with no difference in result. 
To test if lower flowrate and imidazole concentration could help, the flowthrough 
fraction from AMOR-GH57-2 was diluted with binding buffer to a final concentration of 
10mM imidazole and re-applied to the his-trap column. This had no effect.   
Although both AMOR-GH57-2 and AMOR-GH57-4 were soluble, the His-tag were not 
able to bind during purification. Two possible explanations to why these proteins did 
not bind to the column; the first could be a loss of the his-tag after expression, the 
second that the His-tag was folded inside the protein, and thus unavailable for 
attachment to the column. Similar to the CBM9 targets, purification with denatured 
AMOR-GH57-2 and AMOR-GH57-4 using urea should make the His-tag available to 
bind to the column. Results showed that although some of the protein for both AMOR-
GH57-2 (Figure 23) and AMOR-GH57-4 (Figure 24) bound to the column, the protein 
was still present in the flowthrough with the unbound fraction. These results support 
67 
 
the theory that the His-tag in the native form of the proteins is not available to bind to 
the nickel within the column. 
Heat treatment experiments as a purification step of AMOR-GH57-2 and AMOR-
GH57-4 at 60°C, 70°C and 80°C. However, after multiple trials, the results were 
inconclusive. The reasoning for the heat treatments as a purification step was based 
on the origin of these sequences. These originated from the deepest chamber 
(chamber three) of the CGB9 in situ incubator (Stokke et al. 2020), where the 
temperature increases with the depth in the sediment, thus inferring thermostable 
properties of the GH57 target enzymes. Hence, an increased temperature would 
remove the E. coli proteins since they are mesophilic. When looking at the heat 
treatment performed of the 12AMOR1-GH13 protein (Figure 25), there is a difference 
of 14 µg of protein in the soluble fraction and heat-treated soluble fraction, with the 
target protein present in both fractions. This allows for better purification as less protein 
from E. coli could interfere and bind to the His-trap column.  
Overall, the difficulties during purification experiments of AMOR-GH57-2 and AMOR-
GH57-4 were most likely due to the His-tag being unavailable for binding to the column. 
If time would have allowed, synthesizing these genes with a C-terminal his-tag could 
have been performed, and a better solution then trying to optimize renaturing 
conditions. Protein denaturation and refolding, if successful, will also decrease the 
protein concentration. C-terminal expression and purification has been reported 
successful on other GH57 sequences (Zhang et al., 2019). Other purification methods 
which do not rely on an affinity tag could also be considered such as the purification 
and characterization of a thermostable α-amylase from Bacillus cereus where the 
protein was successfully purified with ion exchange chromatography (Annamalai et al., 
2011). Ion chromatography uses the protein net charge to separate the proteins (Vella, 
1987). If ion exchange chromatography would be considered, heat treatment at 60°C 
on the samples first to remove part of the E. coli protein should be aimed for. This 
would increase the possibility to purify the protein when less E. coli protein is present. 
Gel filtration could also supplement the purification by filtering out proteins larger and 
smaller than the targets.  
 
5.4 Isolating active proteins from CBM9 and GH57 candidates  
Plate assays for protein activity against xylan showed no activity on AMOR-CBM9-14 
and AMOR-CBM9-15 (Figure 17), with same results for plate assays with starch for 
AMOR-GH57-2 and AMOR-GH57-4 (Figure 28). The plate tests were not conclusive 
enough to conclude that the proteins had no activity against the substrate tested. The 
major problem is the treatment done with the proteins after expression. When 
denaturing the proteins, this require that the proteins need to be renatured to their 
native state. Here renaturation was tested with dialysis and buffer change. Activity was 
tested with these constructs on 65 °C for 4 hours. Additional tests at 55 °C would have 
been a good supplement to rule out if they were not thermostable at this temperature. 
However, due to low protein yields from protein purification, there was not enough 
sample for the experiment within the time of the project.  
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Two buffers for renaturing and buffer exchange were tested for the CBM9 targets, the 
second with the storage buffer used on AMOR-GH10A. Renaturation of AMOR-GH57-
2 and AMOR-GH57-4 was also tested with dialysis. Difficulties with refolding proteins 
are identifying the best ionic concentration and pH that suit the target protein. Testing 
the samples for correct folding is also a bottleneck. Here the test was done with plate 
activity assay. If the result were positive, this approach would have been good enough. 
However, with negative results from the plate assays it is difficult to assess if correct 
folding has been achieved.   
Other approaches with protein dialysis have shown that stepwise dialysis may increase 
the fraction of active protein. With stepwise dialysis the protein sample is equilibrated 
in multiple stages in buffer that gradually decreases in concentration, allowing the 
protein to first partly refold in dialysis with a lower urea concentration. Then dialysis 
with a buffer without urea to induce refolding back to native structure (Yamaguchi & 
Miyazaki, 2014). Protein loss is problem with protein denaturation and renaturation. 
AMOR-CBM9-14 and AMOR-CBM9-15 went from 9.8ml with a protein concentration 
of 0.220 mg/ml and 0.250 mg/ml respectively to 200µl 0.095 mg/ml and 500µl 0.095 
mg/ml. AMOR-GH57-2 and AMOR-GH57-4 went from 9.8ml with a concentration 
0.0292 mg/ml and 0.0260 mg/ml respectively to 200µl 0.102 mg/ml and 0.122 mg/ml. 
This shows that protein loss was a problem.  
 
5.5 Oligomeric state of the thermostable Geobacillus sp. 12AMOR1 
neopullanase 
The difficulties with expressing AMOR-CBM9 and purifying the AMOR-GH57 target 
proteins shows that protein expression and purification from environmental 
metagenome samples is not straightforward that could be implemented the same way 
for different proteins. However, AMOR-GH10A that originates from the same 
metagenome as the CBM9 targets, and the 12AMOR1-GH13 which originates from a 
bacterial isolate, were successfully purified and active after first attempt. 
From the theoretical molecular weight calculation of 12AMOR1-GH13 it is estimated to 
be 68kDa, which fits with the SDS-PAGE where the band is close to the 65kDa marker 
(Figure 25.B). Using gel filtration spiked with standards, the molecular weight was 
calculated to be 105.5kDa. During gel filtration the protein is purified in its native state, 
hence, when the size is near double of the denatured state this suggest that the protein 
is a dimer. Knowing the oligomeric state of the protein can often be used to determine 
the activity and binding affinity of the protein (Hashimoto & Panchenko, 2010). Gel 
filtration with size exclusion is not the most accurate method to calculate molecular 
size, however, it gives a good estimate. For more accurate measurements analytical 
ultracentrifugation may be performed on the samples. Analytical ultracentrifugation can 
be performed as sedimentation velocity or sedimentation equilibrium, both can be used 
to calculate molecular weight of proteins (Cole et al., 2008) 
In the paper from Wissuwa et al. the growth of Geobacillus sp. was in the temperature 
range of 40-70°C and the melting temperature for 12AMOR1-GH13 was estimated to 
be 76,4°C. The plate assay for starch degradation showed that 12AROR1-GH13 was 
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active in the range that was tested between 40-65°C. Higher temperatures was not 
tested as agar plates start to melt above 65°C, although other solutions such as gelrite 
in the plates could substitute agar at high temperatures. If time would have allowed in 
the current project, the pH range of 12AROR1-GH13 could have been analyzed since 
knowing the optimal activity parameters are important when considering proteins for 
their enzyme activity to be utilized in industrial processes. 
 
6. Conclusion  
Two selected CBM9 sequences was selected for expression, purification and activity 
analysis. Expression was achieved in the temperature range 20°C – 37°C while protein 
aggregated as inclusion bodies. However, purification was achieved under denaturing 
conditions. Refolding of the target proteins against xylan resulted in no activity 
observed at 65°C.  
Two annotated GH57 α-amylase sequences were expressed as soluble protein both 
with and without glycylglycine in the media. Purification was achieved under denaturing 
conditions.  Although refolding resulted in soluble proteins, no activity against starch 
was observed at 65°C.  
The 12AMOR1-GH13 neopullulanase was purified in the native state with a monomeric 
molecular weight estimated with SDS-PAGE at 65kDa, and oligomeric state estimated 
to be dimeric. 
 
7. Future perspectives  
The novelty in finding new enzymes for biotechnology is important amongst others 
for efficient processes. Identifying their ecological role could also strengthen our 
ability to fully utilize the enormous potential of deep-sea hydrothermal enzymes. 
Mapping enzyme targets to metagenome-assembled genomes from the same 
samples enables a further study of the ecological roles of secreted CAZy enzymes. 
To further confirm the activity of the putative xylanases, expression with a variety of 
fusion partners should be considered to obtain the proteins in a native state. A larger 
study on substrate and temperature screening of both the CBM9 and the GH57 
targets should also be conducted since we know little about substrate specificity.  
AMOR-GH57-2 and AMOR-GH57-4 should be tested with new affinity tag placement. 
Testing Hit-tag placement on the C-terminal or considering ion exchange 
chromatography to purify the proteins and avoiding denaturation.  
The 12AMOR1-GH13 neopullulanase activity should be further tested to find optimal 
pH range.   
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9.1 Appendix Buffers  
 
B1 - Lysis buffer:   
50mM Hepes   
300mM NaCl  
10% glycerol (99%)  
MiliQ water 
pH 7.5  
 
B2 - Lysis buffer: 
50mM Tris  
500mM NaCl  
5mM Imidazole  
10% Glycerol (99%) 
MiliQ water  
pH 8.5  
 
B3 - Lysis buffer 
50mM Tris  
500mM NaCl  
5mM Imidazole  
MiliQ water 
pH 8   
 
B4 - Binding buffer   
20mM Hepes   
500mM NaCl   
MiliQ water 1L   
pH 7.5   
 
B5 - Binding 
buffer (10mM imidazole) 
20mM Hepes  
500mM NaCl  
10mM Imidazole   
MiliQ water 1L  
pH 7.5  
 
B6 - B Binding 
buffer (20mM imidazole)   
20mM Hepes  
500mM NaCl  
25mM Imidazole   
MiliQ water 1L  






B7 - Binding buffer 
(Urea)  
20mM NaPO4   
20mM Imidazole  
500mM NaCl  
8M Urea  
pH 7.5  
 
B8 - Binding 
buffer (AMOR-GH10A) 
5mM Imidazole  
50mM Tris HCl  
500mM NaCl  
pH 8 
 
B9 - Binding 
buffer (12AMOR-GH13)  
50mM Sodium Phosphate  
300mM Sodium Chloride  




B10 - Elution buffer  
20mM Hepes   
500mM NaCl  
500mM Imidazole  
pH 7.5   
 
B11 - Elution buffer 
(Urea)  
20mM NaPO4   
20mM Imidazole  
500mM NaCl  
8M Urea  
pH 7.5  
 
B12 - Elution buffer 
(AMOR-GH10A) 
500mM Imidazole  







B13 - Elution buffer 
(12AMOR1-GH13) 
50mM Sodium Phosphate 





B14 - Running buffer:  
0.02M Hepes   
300mM NaCl   
MiliQ water 
pH 7.5  
 
 
B15 - Storage buffer 
0.02M NaPO4   
0.5M NaCl   
pH 7.5  
 
 
B16 - Storage buffer  
50mM Sodium Acetate  
500mM NaCl  
pH 5.6  
 
B17 - Storage buffer  
20mM Potassium 
Phosphate  
100mM Sodium Chloride  
pH 7.5  
 
B18 - Phosphate buffer 
(DSC) 
1M KH2PO4  
1M K2HPO4 
pH 7.4  
79 
 
9.2 Appendix Media   
 
M1 - Lysogeny Broth 
(LB) 
10g NaCl 
10g Tryptone  
5g Yeast extract  
MiliQ H2O to final 
volume 1L  
 
M2 - Terrific Broth (TB) 
24g Yeast extract  
20g Tryptone  
4ml Glycerol (99%)  
Phosphate buffer TB 
(100ml)  
0,017M KH2PO4/ 
0,072M K2HPO4  
MiliQ H2O to final 
volume 1L  
M3 – Agar plates 
10g NaCl  
10g Tryptone  
5g Yeast extract  
20g Agar  
 
M4 – Starch plate 
3g Agar  
2g Starch  
2M phosphate buffer  
200ml H2O 
 
M5 – Xylan plates  
3g Agar  
2g Starch  



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































9.4 Appendix Gel filtration scatter plot  
 
 
scatter plot used to calculate the molecular weight for 12AMOR1-GH13. Log of molecular weight of the known 
standards plotted against the calculated Kave for the standards. Trendline used to calculate the molecular weight 
of 12AMOR1-GH13 
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